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Summary 
Linear eukaryotic chromosomes are characterized by having distinct DNA ends. 
These ends, designated telomeres, are threatened by continued shortening in replication, 
nucleolytic degradation and unwanted fusion by the DNA-repair machinery. In order to 
counteract these processes, eukaryotic cells have evolved a protective cap, designated 
shelterin, which is assembled at telomeric repeats. In fission yeast, shelterin consists of the 
Taz1-Rap1 front-end that binds double strand telomeric repeats and the Pot1-Tpz1-Ccq1 
assembly that is associated with the single strand 3’ overhang. A small protein designated 
Poz1 bridges the two halves and has been shown to negatively regulate telomerase, the 
enzyme that synthesizes telomeric repeats. We set out to investigate the molecular details of 
the poorly characterized protein Poz1 and its interaction with Tpz1 in an effort to gain insight 
into the mechanisms of telomere length regulation. 
Here we present the crystal structure of spPoz1
30-249 
bound to spTpz1
475-508 
at 2.4 Ǻ 
resolution. Our structure remarkably resembles the structure of the TRF-homology domain 
(TRFH) of the human shelterin components TRF1 and TRF2. TRFH acts as a dimerization 
module in human shelterin. We speculated that also Poz1 functions as a dimerization module 
in fission yeast shelterin, a hypothesis that we subsequently validated by mutational analysis 
and size-exclusion chromatography. We revealed that Poz1 by itself is monomeric and upon 
binding of Tpz1 a Poz1-Tpz1 heterotetramer is formed. Furthermore, we showed that also in 
vivo heterotetramerization is essential for maintaining proper telomere length. Together with 
the previously reported dimeric existence of Taz1 and Rap1, as well as the recent discovery 
that Pot1 can dimerize upon telomere binding, these findings suggest an overall dimeric 
arrangement of the components in the fission yeast shelterin complex.  
We replaced Poz1 by the structurally similar human TRF2H-dimerization domain and 
its binding partner hApollo. While poz1Δ strains show very long telomeres, the TRF2H-
Apollo strain showed slow progressive telomere shortening. We suggest that shelterin 
function was mostly restored because TRF2H-Apollo imitates the primary function of Poz1, 
which is linking the double-strand and the single-strand binding halves of shelterin complex 
in a dimeric fashion. Likely, slow telomere shortening is observed because the interactions 
between Rap1-Poz1-Tpz1 are likely dynamic and regulated, but TRF2H and Apollo were 
fused to Rap1 and Tpz1 respectively, not allowing association and dissociation, leading to 
disrupted telomere regulation. 
  iv 
Furthermore, the structure revealed a zinc binding site at the binding interface of Poz1 
and Tpz1. Disruption of the zinc site does not affect Poz1-Tpz1 interaction, but leads to 
decreased solubility of the complex in vitro and long telomeres in vivo. Consequently, 
binding of zinc is essential for the structural integrity of the complex. 
Ultimately, by determining the crystal structure of Poz1
30-249
+Tpz1
475-508
, we 
uncovered new details of the architecture of the fission yeast shelterin complex and revealed 
striking similarities to structural elements found in human shelterin. Furthermore we 
examined the delicate interplay between the shelterin components and how essential its 
integrity is for proper telomere length homeostasis. 
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1. Introduction 
1.1 Telomeres, their function and difficulties they need to overcome 
 
The genomes of prokaryotes and eukaryotic organelles are usually circular, as are 
most plasmids and viral genomes. Eukaryotic genomes on the other hand, are organized into 
multiple linear chromosomes. The ends of linear DNA create two major problems that the 
cells must counteract. First the DNA-replication machinery is unable to replicate linear DNA 
to completion, referred to as the end-replication problem. Without a mechanism in place to 
solve this problem, each round of DNA replication, would result in a loss of a short stretch of 
DNA, which eventually would lead to death by senescence. Secondly, without a protection 
mechanism, chromosome ends would be recognized as double strand breaks (DSBs) by the 
DNA-repair machinery and would be subjected to exonucleolytic degradation, recombination 
and end-to-end joining. The formation of dicentric chromosomes would have fatal 
consequences for the cell by causing severe problems during chromosome segregation. 
 
Most organisms share a common solution for protecting their chromosomal ends from 
the threatening cellular environment. This is the telomerase-based solution. Here, the ends of 
chromosomal DNA are organized into repetitive protein-DNA complexes know as the 
telomeres. These allow the regulation of the reverse transcriptase telomerase, which can 
synthesize telomeric DNA thereby counteracting the loss of DNA caused by incomplete 
replication. Furthermore, the proteins that bind to the telomeric DNA have the ability to 
repress the DNA-repair machinery and in this manner, degradation, recombination and end-
fusions are inhibited.  
 
While the proteins that bind the telomeres and regulate the telomerase enzyme vary to 
some extent in composition and function from organism to organism, the principal of 
synthesizing telomeric repeats to the chromosomal ends by means of telomerase is conserved 
among many species ranging from yeast over ciliates and mice to humans. Although rare, 
some plants and animals have lost the telomerase enzyme during the course of evolution. 
These organisms maintain their chromosome ends by telomerase-independent mechanisms. 
Some plants such as the family of nightshades (Solanaceae) (Fajkus et al., 1995; Peska et al., 
2008; Sykorova et al., 2003; Watson & Riha, 2010) and onion (Allium cepa) (Pich et al., 
1996; Pich & Schubert, 1998) have been reported to lack telomerase. While for Solanaceae 
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the compensation mechanism for maintaining the telomeres remains unknown, A. cepa 
telomeres are thought to be maintained by transposable sequence-elements within the 
telomeres or homologous recombination between satellite telomere sequences. A far better 
characterized mechanism for telomerase-free telomere maintenance is present in the fruit fly 
(Drosophila). Drosophila lacks telomerase (Sasaki et al., 2000) and telomeres are elongated 
by occasional transposition of specialized retroelements (Mason et al., 2008; Capkova et al., 
2008; Pardue et al., 2008). Furthermore, the Drosophila telomeres are bound by a multi-
protein complex called terminin in a sequence independent manner, which has been shown to 
be essential for protection against telomere fusions (Cenci et al., 2005). The terminin 
components are not conserved outside of Drosophila. It has been suggested that during the 
course of evolution the telomerase-based telomere elongation mechanism was lost and 
Drosophila rapidly evolved the terminin complex to protect its telomeres (Raffa et al., 2011).  
 
Since this work centers around the telomeres of fission yeast (Schizosaccharomyces 
pombe), the introduction of my thesis will focus on the telomerase-based maintenance 
system. I will describe the architecture of the telomeres with the proteins that bind them and 
what is known about the regulatory mechanisms that maintain the integrity of the 
chromosome ends. Human telomeres will also be highlighted as they share many structural 
and functional similarities with fission yeast telomeres. I will also give an overview of 
structural data that is available to date on the proteins associated with the telomeres.  
 
 
1.1.1 Telomeric DNA sequences 
 
In most eukaryotes, telomeric sequences are organized in a similar manner: short 
tandem repeats, which are G-rich in the strand containing the 3’ end. This strand is referred to 
as the G-strand, while the complementary strand is called the C-strand. However the actual 
telomeric sequence varies among different species, as does the number of telomeric repeats. 
In cells that express telomerase, telomere length is kept within a narrow species- and cell-
type specific range. The length of the double strand telomeric repeats ranges from <30 bp in 
some ciliates (Klobutcher et al., 1981), ~300 bp in yeast (Shampay et al., 1984), 5-15 kbp in 
humans (Moyzis et al., 1988) and up to ~150kbp in mice (Kipling, 1990). Fission yeast 
telomeres were first cloned and sequenced in the 1980s by Sugawara and Szostak. They are 
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comprised of a degenerate telomeric repeat (G2-6TTAC[A]) spanning the terminal ~300 bp of 
each chromosome. Irregular telomeric repeats have also been found in budding yeast 
(Szostak & Blackburn, 1982; Shampay et al., 1984; Forstemann & Lingner, 2001). Mammals 
use the sequence TTAGGG for the telomeric repeats at their chromosome ends (Moyzis et 
al., 1988; Meyne et al., 1990). The length of the telomeric repeat tracts varies among 
different mammals, but for humans is generally in the range of 5-15 kb. The advantages of 
the extraordinarily long telomeres found in mice and rats are currently unknown (Kipling, 
1990). 
 
The actual terminus of chromosomal ends is not blunt but consists of an extension of 
the 3’ end of the G-strand known as the 3’ overhang or G-tail. This feature is conserved 
among most species in the eukaryotic kingdom. For Drosophila that lacks telomerase, a 3’ 
overhang has also been suggested given the lower occupancy of some of the telomere binding 
factors at the extreme ends, but this hypothesis has not been confirmed (Gao et al., 2010). 
The 3’ overhang in yeast ranges from 12 to 100 bases in length (Wellinger et al., 1992 and 
1993), while in human cells the overhang can range between 50-500 nucleotides, which is 
considerably longer than in other eukaryotes (Makarov et al., 1997; Stewart et al., 2003). In 
budding yeast it has been shown that the 3’ overhang length depends on the cell cycle stage 
with longer tails during S-phase (30-100 bases) and shorter tails found during the rest of the 
cell cycle (12-14 bases) (Wellinger et al., 1993; Larrivee at al., 2004). G-tails are suggested 
to be involved in the protection of chromosome ends either by T-loop formation to sequester 
the DNA ends and/or by binding of specific single-strand binding proteins (mechanisms 
described in section 1.4). The formation of the G-tails in S. cerevisiae (Dionne & Wellinger, 
1996; Larrivee et al, 2004) and humans (Chai et al, 2006) is thought to be achieved by C-
strand resection dependent on the Mre11-Rad50-Xrs2 (MRX) and Mre11-Rad50-Nbs1 
(MRN) complexes respectively. In fission yeast, the Rad50-Rad32-Nbs1 (MRN) complex as 
well as the nuclease Dna2 have been implicated in the resection of the C-rich strand (Tomita 
et al., 2004). 
 
1.1.2 The end-replication problem 
 
The end-replication problem was first described arising from the fact, that DNA-
polymerases cannot replicate linear DNA to completion (figure 1.1). DNA-polymerases 
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synthesize DNA only in the 5’→ 3’ direction, allowing normal replication of the leading 
strand. Lagging strand synthesis, on the other hand, cannot be performed in this manner and 
requires short RNA primers. These are used to prime lagging strand DNA synthesis, and are 
subsequently removed. The gaps are filled by DNA-polymerase δ. However, the most distal 
primer cannot be replaced with DNA after removal, leading to a loss of 8-12 nucleotides at 
the 5’ end (figure 1.1B). Early on, this was thought to be the cause of progressive telomere 
shortening with each round of replication (Watson, 1972; Olovnikov, 1973; Cavalier-Smith, 
1974; Bateman, 1975). Later on however, it was discovered that rather than being a lagging-
strand synthesis issue, the progressive loss of DNA at the chromosome ends arises from the 
exonucleolytic degradation. Because leading-strand synthesis results in blunt-ended DNA, 
the 3’ overhang must be generated. This is achieved by 5’→ 3’ exonucleolytic degradation 
occurring on the telomere on which leading strand synthesis has taken place and results in a 
lack of template during the next leading strand synthesis (figure 1.1C) (Lingner et al., 1995). 
With each round of replication, the DNA would get progressively shorter. 
 
However, cells have a mechanism in place to counteract the progressive DNA 
shortening due to incomplete replication and resection with a key player being telomerase. 
 
Figure 1.1. The DNA end-replication problem.  
(A) The initial DNA double-strand with the 3’ overhang. Due to the 5’-3’ directionality of DNA polymerases, replication of 
the lagging strand is achieved by short RNA primers, which are subsequently removed and filled by the DNA polymerases 
(B). The very distal RNA primer however cannot be replaced. The problem unfolds upon replication of the leading-strand: 
exonucleolytic degradation on the telomere on which leading strand synthesis has taken place produces an 
overhang that results in a lack of template during the next leading strand synthesis (C). Without a mechanism to 
counteract this problem, at each round of replication the DNA would get progressively shorter. Adapted from Grandin and 
Charbonneau, 2008).  
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1.1.3 DNA-damage response in telomere regulation 
 
Another threat to the liner DNA-ends is the DNA-repair machinery. DNA double-
strand breaks (DSBs) must be repaired to maintain genomic integrity. This is achieved by 
joining of the DNA ends by homologous recombination (HR) and non-homologous-end-
joining (NHEJ). Since telomeres are natural DNA termini, they could potentially be 
recognized as DNA double-strand breaks (DSBs) by the checkpoint machinery. This would 
lead to inadvertent joining of the chromosomal ends resulting in dicentric chromosomes and 
breakage-fusion-cycles during cell division (McClintock 1938 and 1941). However, this 
scenario is circumvented through telomeres. Specific proteins assemble at the telomeric 
repeats and protect them from the DNA repair machinery.  
 
In general, in the presence of DNA damage, the activation of checkpoint proteins 
pauses the cell cycle, giving the cell sufficient time to repair the damage before starting DNA 
replication and mitosis (Sancar et al., 2004; Humpal et al., 2009). Mammalian cells are 
alerted to lesions in their genome by two phosphatidylinositol 3-kinase-related protein 
kinases called ATM and ATR (figure 1.2) (reviewed by Shiloh 2003). While the ATM 
pathway is thought to respond primarily to double-strand breaks (DSBs), ATR comes in 
response to the formation of ssDNA. 
 
 
 
Figure 1.2. The DNA-damage response. 
ATM and ATR pathways in humans. Figure adapted from Palm and de Lange, 2008. 
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These complexes promote the accumulation of other DNA damage response factors and 
they phosphorylate two nucleoplasmic effector kinases, Chk1 and Chk2, which can block cell 
cycle progression until damaged DNA has been fixed. 
 
In fission yeast, these DNA damage sensor kinases are called Tel1
ATM
 and Rad3
ATR
 
(where the superscript corresponds to the human orthologue). Paradoxically, while Tel1
ATM
 
and Rad3
ATR
 activate the DNA repair machinery and thereby present a threat to linear DNA 
ends, it has been shown in fission yeast that they are also required to be present at the 
telomeres in order to phosphorylate the telomere protein Ccq1 (Moser et al., 2011). Failure to 
phosphorylate Ccq1 results in the failure of the recruitment of telomerase to telomeres and 
leads to gradual shortening of telomeres (Yamazaki et al., 2012) (more in section 1.4.3). 
 
 
1.2 Telomerase 
 
Cells require a special mechanism to counteract the progressive shortening of the ends 
of linear DNA (described in section 1.1.2). A key player in this mechanism is the 
ribonucleoprotein complex known as telomerase (figure 1.3), first discovered in 1985 in 
Tetrahymena thermophila by Carol Greider and Elizabeth Blackburn (Greider and Blackburn, 
1985). Telomerase catalyzes the addition of telomeric repeats to the 3’ overhang and consists 
of a reverse transcriptase protein and a large RNA component, which provides the template 
sequence for the telomeric repeat (Greider and Blackburn 1989, Lingner et al., 1997).  
 
A 
 
B 
 
 
Figure 1.3. The telomerase reverse transcriptase complex. 
Schematic view of A) the human and B) fission yeast telomerase complex. Figures adapted from Smogorzewska and Lange, 
2004) 
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In humans, telomerase is composed of the reverse transcriptase TERT and the RNA 
moiety TERC, which contains the template for synthesis of the telomeric repeats (Feng, 
1995; Lingner, 1997; Nakamura, 1997). While the TERT protein subunit is highly conserved 
among eukaryotes, the RNA component of telomerase diverged quite quickly in evolution 
and differs in length and sequence among different species. The telomerase RNAs do 
however share some common features among different species. This includes an open loop 
containing the template and the pseudoknot. In fission yeast the protein subunit is called Trt1 
(Nakamura, 1997), while the RNA component had resisted discovery for a long time. Only 
recently the Baumann and Zakian groups (Leonardi, 2008; Webb, 2008) identified fission 
yeast TER1 as a 1213 nucleotide RNA, which is significantly longer than its human 
counterpart TERC (which comprises 451 nucleotides). Ter1 mediates interactions between 
Trt1 and Est1, Est1 being a telomerase accessory protein. Homologous Est telomerase 
accessory proteins are also found associated with telomerase in S. cerevisiae and humans. In 
S. cerevisiae it has been shown that Est proteins are not required for telomerase catalysis in 
vitro (Cohn, 1995; Lingner, 1997), but in vivo they have been shown to be essential and their 
deletion leads to progressive telomere shortening, known as the ever-shorter-telomeres (est) 
phenotype (Lundblad, 1989; Lendvay, 1996). In fission yeast, it has been shown that the 
interaction of Est1 with the telomere binding protein Ccq1 mediates telomerase recruitment 
to the telomeres (Webb and Zakian, 2012) (see also section 1.4.3). Moser and colleagues 
have shown that phosphorylation of Ccq1 by Tel1 and/or Rad3 is required for the Ccq1-Est1 
interaction which goes in line with the failure to recruit telomerase in a Ccq1 mutant that 
cannot be phosphorylated (Moser et al., 2011). 
 
In 1997, Prescott and Blackburn found, that S. cerevisiae telomerase functions at least 
as a dimeric complex with two active sites and that it can bind multiple telomere substrates 
simultaneously. Similarly, Wang et al. (2002) showed also that telomerase in the ciliate 
Euplotes crassus has the ability to form dimers and furthermore human telomerase was 
shown to oligomerize (Beattie et al., 2001). Two models are proposed for the coordinated 
action in a telomerase dimer where in one model the dimeric complex binds two substrates 
simultaneously with its two active sites and in a second model the two catalytic sites act 
sequentially on a single substrate in a template switching hand-off mechanism (Prescott and 
Blackburn 1997, Wenz et al., 2001). Whether telomerase in fission yeast also exists as a 
multimeric complex remains to be determined, but it is certainly likely given the conservation 
of multimerization from ciliates over yeast to humans. 
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1.3 The shelterin complex 
 
DNA ends of chromosomes are threatened by the end-replication problem and the 
DNA-damage repair machinery. In order to regulate the action of telomerase which deals 
with telomere shortening, and inhibit the DNA-repair machinery, a number of proteins need 
to assemble at the telomeric repeats. These proteins together form a large complex, found in 
many species, and is known as the shelterin complex (figure 1.4).  
 
 
 
Figure 1.4. Shelterin complexes across different species.  
While the complexes in humans and fission yeast (S. pombe) share several similarities, the S. cerevisiae complex has 
strongly diverged in composition. Figure adapted from Longhese et al., 2012. 
 
 
 The shelterin complex is best described in S. cerevisiae, fission yeast (S. pombe) and 
humans. While the protein composition in S. cerevisiae has strongly diverged, the complexes 
in fission yeast and humans are more alike. Since my thesis centers on the fission yeast 
shelterin complex, the introduction will mainly focus on this complex and I will and the 
comparison to the human shelterin complex. 
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1.3.1 Fission yeast shelterin 
 
In fission yeast, the shelterin complex is composed of Taz1-Rap1-Poz1-Tpz1-Ccq1-
Pot1. Some of the components have only recently been discovered and are not well 
characterized as of yet. Taz1, a 663 amino acid protein, binds to telomeric repeats via its N-
terminal Myb-related DNA binding domain, also known as the telobox (Bilaud et al., 1996) 
which is also found in the homologous human telomeric proteins TRF1 and TRF2 (Cooper et 
al., 1997) (figure 1.5). Taz1 has been shown, as TRF1 and TRF2, to form homodimers in 
order to enable binding double-strand telomeric repeats (Spink et al., 2000). In TRF1 and 
TRF2, dimerization occurs via the TRF homology domain (TRFH) (Broccoli et al., 1997), 
which can be observed in the X-ray structure (Fairall et al., 2001). The TRFH domain has 
also been predicted in Taz1 and it is assumed that also here, this domain is responsible for 
dimerization (figure 1.5) (Li et al., 2000). Taz1Δ fission yeast strains generate severely 
elongated telomeres suggesting a role for Taz1 in restricting telomere elongation (Cooper et 
al., 1997). Taz1 has furthermore been implicated in efficient replication fork progression 
through the telomere, and loss of Taz1 leads to stalled replication forks (Miller et al., 2006). 
 
 
 
 
Figure 1.5. Sequence alignment of spTaz1, hTRF1 and hTRF2.  
The TRF homology module and the Myb DNA-binding domain are found in each of the proteins. The sequence identity 
(black) and similarity (grey) are given in percent. Adapted from Li et al., 2000. 
 
 
 Rap1, a 693 amino acid protein binds via its C-terminus to the central region of Taz1 
(residues 365-396) and has been suggested to bind as a dimer to dimeric Taz1 (Chikashige 
and Hiraoka, 2001). Despite similarities between different species, Rap1 in S. cerevisiae 
functions differently in that it directly binds to the DNA, while in fission yeast and in 
humans, Rap1 does not have DNA binding ability and instead indirectly binds to the 
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telomeres (see figure 1.4). Fission yeast Rap1 contains an N-terminal BRCT domain 
followed by a Myb-domain, both also present in S. cerevisiae and human RAP1 (figure 1.6). 
BRCT domains (first described in the breast cancer protein BRCA1, Koonin et al, 1996) are 
conserved domains frequently found in DNA damage-responsive cell cycle checkpoint 
proteins (Bork et al., 1997). BRCT domains bind phosphoproteins and phosphopeptides 
containing the pS-X-X-F recognition motif (Glover et al., 2004) but have also been reported 
to allow protein-protein recognition via direct BRCT-BRCT contacts (Zhang et al., 1998). 
Furthermore, the Crb2 fission yeast DNA-damage response protein has been shown to 
homodimerize via its BRCT domain (Willson et al., 1997). The hypothesis that spRap1 
dimerizes via its BRCT domain remains to be proven.  
 
 Rap1Δ strains show long telomeres similar to Taz1Δ (Chikashige et al., 2001). 
Furthermore, Rap1 has been shown to collectively with Taz1 regulate 3’ overhang formation 
as well as prevent telomere fusions (Miller et al., 2005). Rap1 also has functions outside 
telomere length regulation: The meiotic proteins Bqt1 and Bqt2 together form a link between 
Rap1 and spindlepole body protein Sad1, and these interactions have been shown to be 
essential for bouquet formation (bundle arrangement of chromosomes) which plays an 
important role in homologous chromosome pairing and progression of meiosis (Chikashige et 
al., 2006).  
 
 
 
Figure 1.6. Sequence alignment of human, fission yeast and S. cerevisiae Rap1.  
The  BRCT domain and the Myb-domain are shared features. Adapted from Chikashige and Hiraoka, 2001. 
 
 
 In 2011, Chen et al. published the NMR solution structure of the C-terminal domain 
of Rap1 in complex with a peptide of Taz1 (figure 1.7). It revealed remarkable similarities of 
the architecture and interaction of Rap1-Taz1 compared to the human homologues RAP1-
TRF2, whose crystal structure was solved in the same study.  
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Figure 1.7. Superposition of spRap1639-693-Taz1365-396 and hRAP1303-399-hTRF2275-316. 
SpRap1 is colored in blue, hRAP1 in green and grey, spTaz1 in orange and hTRF2 in yellow. (Chen et al., 2011). 
 
 
 Poz1, a short 249 amino acid protein binds to Rap1 (Miyoshi et al., 2008). The 
protein sequence of Poz1, allowed no predictions about sequence motifs or structural 
domains. Poz1Δ cells exhibit very long telomeres (up to 2000bp). Thus Poz1 has been 
proposed to be implicated in telomere shortening by negatively regulating telomerase. This is 
furthermore underlined by Poz1Δ/TrtΔ (telomerase) double mutants that do not show the long 
telomere effect (Miyoshi et al., 2008). Poz1 binds to a 508 amino acid protein called Tpz1. 
 
 Tpz1 contains a predicted N-terminal OB-fold (oligonucleotide/oligosaccharide 
binding domain, Murzin et al., 1993) of which sequence and secondary structure elements 
align well with the structure of the OB-fold of the human Tpz1-homologue TPP1 (figure 1.8) 
(Wang et al., 2007). Tpz1, in turn, makes interactions with Poz1 via its C-terminal residues 
(379-508) and the interaction with Pot1 (described later) via the N-terminal OB-fold 
(Miyoshi et al., 2008). Tpz1Δ cells do not grow or form only very small colonies. Surviving 
cells exhibit a complete loss of telomeric DNA as well as self-circularization, similar to 
Pot1Δ cells (discussed below), indicating that Tpz1 is required for the protection of DNA 
ends against unwanted fusions (Miyoshi et al., 2008). Furthermore, Tpz1 is found at the core 
of the shelterin complex and it is not surprising that its removal causes major telomere 
dysfunction. 
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Figure 1.8. Sequence alignment of spTpz1 and its homologues. 
SjTpp1 is from Saccharomyces japonicus, a closely related fission yeast species. OnTEBP-β is the telomere end-binding 
protein from Oxytricha nova, a ciliated protozoan (Horvath et al., 1998, Gray et al., 1991). Red (bar) and blue (arrow) letters 
represent α-helices and β-strands, respectively. SpTpz1 and sjTpp1 1 share the α−β−β−β−α−β−β−α structure that is 
commonly observed in OB folds of telomere-related proteins, including hTPP1 and OnTEBP-β. 
 
 
 The binding site for Ccq1 is also found within the C-terminal region (residues 379-
508) of Tpz1. Ccq1 is a 735 amino acid protein. Residues 1-436 are predicted to contain a 
HEAT repeat domain and its C-terminal residues 500-720 are predicted to form a coiled-coil 
domain (Flory et al., 2004). Ccq1 has been implicated not only in telomere regulation, but 
also plays a critical role during meiosis (Flory et al., 2004). To date, no proteins homologous 
to Ccq1 have been found in S. cerevisiae or humans. Ccq1Δ cells show shortened telomeres 
(by ~200bp) which implicated Ccq1 as a positive regulator of telomerase and therefore 
responsible for telomere elongation (Miyoshi et al., 2008). Furthermore, Ccq1 has been 
shown to be required for proper telomerase recruitment to the telomeres (Webb and Zakian, 
2012) (see also section 1.4.3). 
 
 The sixth component of the fission yeast shelterin complex is a protein called Pot1 
(Baumann and Cech, 2001). Pot1 is 555 amino acids long and binds via its C-terminal region 
to the    N-terminal OB-fold in Tpz1 (Miyoshi et al., 2008). Pot1 binds to the single-stranded 
G-rich 3’ overhang of the telomeric repeats via its N-terminus and the crystal structure 
thereof was solved by Lei et al. in 2003 (figure 1.9).  
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Figure 1.9. The structure of spPot11-185 (N-terminal OB-fold) in complex with a ssDNA telomeric repeat (GGTTAC). 
α-Helices of Pot1 are colored in red, β-sheets in yellow. DNA is shown as a stick model with carbon in green, nitrogen in 
blue, oxygen in red and phosphorus in orange (Lei et al., 2003). 
 
 
 While the structure of Pot1 solved only shows the N-terminal OB-fold bound to a 
telomeric repeat, it was later shown that fulllength Pot1 has two N-terminal OB-folds and 
binds to two telomeric repeats via OB1 and OB2, thereby increasing its binding affinity 
(Trujillo et al., 2005). Binding via two OB-folds has been suggested to accommodate 
telomeric substrates with different spacer lengths: As opposed to mammalian telomeres, 
fission yeast telomeres contain spacers of different lengths in between the telomeric repeats. 
(reviewed in Zakian, 1995). The structure of human POT1 revealed how two N-terminal OB-
folds bind ssDNA (Lei et al., 2004). Recently it was shown, that besides binding two 
telomeric repeats via OB1-OB2, spPot1 can dimerize upon binding to the DNA, thereby 
binding two telomeric repeats via the OB1 of each molecule (Nandakumar and Cech, 2012). 
The Cech group reported, that when the 3’ overhang is very short (too short to be 
accommodated by OB1 and OB2), then two spPot1 molecules bind two telomeric repeats in a 
dimeric fashion via their OB1-folds. One explanation states that this strategy could have 
evolved to maintain end-protection of short overhangs that cannot be bound by a Pot1 
monomer due to the incomplete DNA-binding template. Furthermore, they suggested that a 
Pot1-dimer could serve as a platform to recruit two Tpz1 and two Ccq1 molecules that help 
recruit dimeric telomerase (should it be dimeric in fission yeast, see section 1.2), which in 
turn lengthens the telomeres with short overhangs. Dimerization has also been observed for 
another telomeric ssDNA-binding protein, scCdc13, found in S. cerevisiae, which in turn also 
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possesses a heterogeneous telomere sequence (Sun et al., 2011). Pot1Δ strains show a 
complete loss of telomeric DNA and these cells have been shown to survive by chromosome 
circularization (Baumann and Cech, 2001). Thus Pot1 is essential for the protection of 
telomere ends from unwanted fusion events and degradation. 
 
 Taken together, the fission yeast shelterin complex can be divided into the double-
strand binding subcomplex Taz1-Rap, and the single-strand 3’ overhang binding subcomplex          
Pot1-Tpz1-Ccq1, with Poz1 bridging the two subcomplexes. 
 
 
1.3.2 The human shelterin complex 
 
 While the human shelterin complex (Liu et al. 2004b; O'Connor et al. 2004; Ye et al. 
2004a) has a composition that resembles the fission yeast complex in many ways, some 
components have diverged. The major difference being that the human double-strand 
telomeric repeats are bound by two dimeric proteins instead of one (Taz1 in fission yeast), 
and referred to as TRF1 and TRF2 (Zhong et al., 1992; Chong et al. 1995; Ludérus et al., 
1996; Bilaud et al., 1996). These proteins share a common domain structure consisting of the 
TRF homology domain (TRFH) and a C-terminal Myb DNA-binding domain that have also 
been predicted to exist in spTaz1 (figure 1.5). The structure of the Myb DNA-binding 
domain of TRF1 was solved in 2001 (Nishikawa et al., 2001) (figure 1.10).  
 
 
 
Figure 1.10. The structures of the Myb DNA-binding domains of A) hTRF1 and B) hTRF2 in complex with DNA.  
While the sequence identity between TRF1 and TRF2 is 56%, the structures and contacts are almost identical. TRF1 is in 
green, TRF2 in red. DNA is presented in grey. The blue spheres represent conserved water molecules that mediate contacts 
between the protein and the telomeric repeat sequence and increase the specificity and affinity (Court et al., 2005). 
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 TRF1 and TRF2 have the ability to dimerize via the TRFH domain (Broccoli et al., 
1997) and the structures of the dimerization modules have been solved (Fairall et al 2001). 
Recently, the structure of TRF1 was solved in complex with a peptide of its binding partner 
TIN2 and TRF2 with a peptide from the 5’ exonuclease Apollo (figure 1.11) (Chen et al., 
2008; Demuth et al., 2004). Apollo is a shelterin associated factor and is essential for proper 
replication of telomeres as well as end protection (Touzote et al., 1999). TRF1 and TRF2 are 
subject to extensive post-translational control. For TRF1, nine different sites have been 
reported to be phosphorylated by six different kinases which modulates its binding to 
telomeric DNA and its stability (Walker and Zhu, 2012). The majority of the sites localize to 
a flexible linker region between the DNA-binding Myb-domain and the TRFH domain. 
Control of TRF2 by phosphorylation is less well understood. Phosphorylation of T188 in 
TRF2 by ATM has been shown to be implicated in the DNA-damage response (Huda et al., 
2009). Furthermore TRF1 and TRF2 have been shown to be ubiquitylated which targets them 
for protease mediated degradation (Chang et al., 2003; Fujita et al., 2010). Many more post-
translational modifications have been reported that together weave an extensive regulation 
network for TRF1 and TRF2 (Walker and Zhu, 2012). 
 
A
 
B 
 
       
Figure 1.11. Crystal structures of the TRFH-domains of hTRF1 and hTRF2. 
The structures of A) hTRF162-268 in complex with hTIN2256-276 and B) hTRF286-287 in complex with hApollo496-532 . Chen et 
al., 2008. 
 
 
 TIN2 (Kim et al., 1999) is a small protein that simultaneously binds and bridges 
TRF1 and TRF2 and is viewed as the functional homologue of Poz1, despite any obvious 
sequence or predicted structural similarity between them. Given the sequence and structural 
similarity between TRF1 and TRF2, it was assumed that TIN2 would bind the TRFH domain 
Chapter 1 – Introduction  16 
       
 
in both proteins. While TIN2 binds in the TRFH domain in TRF1, the TRFH domain in 
TRF2, however, is not required for binding to TIN2. Instead, TRF2
352-365
, a short region that 
lies C-terminally of TRF2H is required for TIN2 interaction. Thus, the same molecular 
surface that in TRF1 binds TIN2, binds the 5’ exonuclease Apollo in TRF2, while TRF2H 
cannot bind TIN2. The Lei group also showed that TRFH in both, TRF1 and TRF2, attracts a 
number of other shelterin-associated proteins containing a F/Y-X-L-X-P sequence motif (also 
present in TIN2 and Apollo) but with distinct specificities (Chen et al., 2008). These results 
suggest that the TRFH domains of TRF1 and TRF2 function as protein docking sites that 
recruit different telomeric factors with distinct functions. 
 
 Besides binding TIN2, TRF2 also binds RAP1 (Li et al., 2000). Human RAP1, as its 
homologues in S. cerevisiae and fission yeast, contains an N-terminal BRCT domain 
followed by a Myb-domain (figure 1.6). Like fission yeast Rap1, human RAP1 does not bind 
DNA directly as Rap1 in S. cerevisiae does, but rather binds the telomeres indirectly through 
interaction with TRF2. The interaction is mediated by the very C-terminal residues 303-399 
of RAP1 and a central region of TRF2 which corresponds to residues 275-316. The X-ray 
structure of this interaction (described in section 1.3.1 (figure 1.7)) strongly resembles the 
interaction of the homologues in fission yeast, Rap1-Taz1. RAP1 has been implicated in 
inhibiting chromosome fusions by non-homologous end joining and is recruited to the 
telomere by TRF2 (Sarthy et al., 2009). 
 
 TPP1 is the human homologue of fission yeast Tpz1 (Liu et al., 2004, Ye et al., 2004) 
and binds to TIN2 via its C-terminal region (334-544). An OB-fold had been predicted in its 
N-terminus and was later verified by a crystal structure (figure 1.12a) (Wang et al., 2007). A 
remarkable similarity of TPP1 to Oxytricha nova telomere end-binding protein TEBP-β was 
observed despite the low sequence identity of only 11% (figure 1.12b). This includes also 
three peripheral α-helices outside the OB-fold, suggesting that TPP1 is not merely another 
OB-fold containing protein, but shares common ancestry with onTEBP-β. Given the 
remarkable conservation from human to Oxytricha nova and the prediction of the OB-fold in 
the orthologous spTpz1 it can be assumed that Tpz1 might have a similar architecture, 
although no structure thereof has been solved to date. TPP1 together with POT1 have been 
shown to increase the processivity of telomere extension by telomerase (Wang et al., 2007). 
Furthermore, it seems that a subdomain of human telomerase (TERT) called DAT 
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(dissociates activities of telomerase), interacts with TPP1 thereby recruiting telomerase to the 
telomere (Armbruster et al., 2004; Zaug et al., 2010). 
 
 
 
Figure 1.12. Comparison of hTPP1 to its homologues.  
a) The crystal structure of hTPP1-OB (87-344). b) Superposition of hTPP1-OB onto the crystal structure of the OB-fold of 
onTEBP-β. c) the more distantly related second Oxytricha nova telomere end-binding protein TEBP-α. (Wang et al., 2007). 
 
 
 The final component of the human shelterin complex is POT1 (Baumann and Cech, 
2001). Human POT1, similar to fission yeast Pot1, binds the telomeric single-strand G-rich 3’ 
overhang. The structure of POT1 (figure 1.13) revealed two N-terminal OB-folds that both 
bind to the ssDNA (Lei et al., 2004), a binding mode that has also been suggested for fission 
yeast Pot1 (Croy et al., 2006). POT1 has been predicted to contain a third OB-fold in its C-
terminus which constitutes an arrangement similar to the three OB-folds found in the 
Oxytricha nova homolog TEBP-α, suggesting common ancestry. However, the architecture of 
the chromosome ends in humans and Oxytricha nova have diverged. While humans have a 
long 3’ G-rich single-strand overhang, the DNA-ends in Oxytricha nova merely consist of a 
16-nucleotide, 3’-terminal, single strand T4G4T4G4 extension. This results in a different 
arrangement of the single-strand binding complexes: TEBP-α together with TEBP-β sits as a 
single complex at the very end of the on the 3’ overhang and buries the 3’ DNA-end within 
the complex preventing any access by telomerase (figure 1.14) (Horvath et al., 1998). In 
humans, the mechanism has become more complex and hPOT1 coats the entire single-strand 
overhang (Loayza et al., 2004) and cooperatively with the other shelterin components, the 3’ 
end is sequestered in a loop structure termed the T-loop (Griffith et al., 1999) (see section 
1.4).  
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Figure 1.13. The crystal structure of hPOT15-299. 
Telomeric ssDNA is bound by OB1 and OB2. A similar architecture has been predicted for fission yeast Pot1, though only 
the structure of spPot-OB1 has been solved. α-Helices of POT1 are colored in red, β-sheets in yellow. DNA is shown as a 
stick model with carbon in white, nitrogen in blue, oxygen in red and phosphorus in orange. (PDB=1XJV, Lei et al., 2004. 
Figure generated with PyMOL, deLano, 2002). 
 
 
 
Figure 1.14. Crystal structure of the onTEBP-α/β telomere end-binding complex.  
The very 3’ end of the telomeric DNA is buried completely within in the complex. Unlike hPOT1 and spPot1 that coat the  
3’ overhang, this complex actually sits at the very end of the DNA (Horvath et al., 1998). 
 
 
1.4 Current models of telomere length regulation by shelterin 
 
In yeast and mammals, the length of telomeres is maintained within a set size-range 
by a negative feedback loop that blocks the action of telomerase at individual chromosome 
ends. When a given telomere is very long, the telomerase pathway is restrained allowing the 
telomere to shorten. If the telomeric region is very short, the control is relaxed so that 
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telomerase can restore its length (Marcand et al., 1997). Besides the telomerase enzyme, the 
shelterin complex is a key component in this regulation mechanism. 
 
While much work has been carried out on uncovering details of the mechanisms of 
telomere length regulation in humans, less is known about the situation in fission yeast. In the 
following the current models in humans and fission yeast are discussed. Some aspects remain 
speculative and more evidence is required to prove that these mechanisms indeed function in 
the proposed manner. 
 
 
1.4.1 Model for telomere length regulation in humans 
 
The common model of telomere length regulation is a stochastic process and is also 
known as the “protein counting model” (Marcand et al., 1997) because it is thought that cells 
determine the length of their telomeres by the number of shelterin complexes bound to their 
repeats. The longer the telomeres are, the more shelterin complexes are bound.  
 
More shelterin complexes present at long telomeres (figure 1.15a) are thought to 
increase the loading of the single-strand binding component POT1 onto the telomeric 
overhang (de Lange, 2005). According to the model, the binding of shelterin complexes at 
long telomeres is thought to induce a conformational change in the DNA architecture where 
the chromosomal end is folded back forming the so called T-loop, a phenomenon that has 
been observed in vitro by electron microscopy (Griffith et al., 1999). It was shown that the 
shelterin component TRF2 is able to induce T-loop formation of telomeric DNA in vitro 
(Stansel et al., 2001). The 3’ single-stranded overhang is thought to invade the duplex 
telomeric repeat array with a displacement D-loop at the invasion site (figure 1.15b). The T-
loop is suggested to represent a protective cap at the chromosome end and in this 
conformation it is proposed that the DNA end is hidden inside the structure preventing access 
and its extension by the telomerase enzyme. In the case of short telomeres, fewer shelterin 
complexes are bound which decreases the loading of POT1 onto the single-strand overhang 
which in turn does not allow T-loop formation, leaving the DNA-ends in an open 
conformation, where they are readily accessible and extendable by telomerase. 
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A 
 
B 
 
Figure 1.15. The “protein counting” and T-loop model for human telomere length-regulation.  
A) Situation at the chromosome ends in the case of long and short telomeres. B) Schematic representation of the invasion of 
the duplex DNA by the 3’ single-strand overhang. Adapted from de Lange, 2005. 
 
 
1.4.2 Model for telomere length regulation in fission yeast 
 
The mechanisms of telomere length regulation in fission yeast are less well studied. 
The Griffith group showed in 2004, that like TRF2, Taz1 is able to induce T-loop formation 
in vitro. However, the existence of T-loops in vivo has not yet been determined for fission 
yeast due to technical difficulties in isolating sufficient telomeric fragments for analysis 
(Tomaska et al., 2004). 
 
The common model states (figure 1.16) (Miyoshi et al., 2008, Bianchi and Shore, 
2008) that in the case of long telomeres, there are many double-strand telomeric repeats and 
therefore many Taz1-Rap complexes are bound. The telomeric repeats are counted allowing 
the cell to determine whether the telomeres are long or short. Given the high abundance of 
Taz1-Rap1 molecules bound on long telomeres, all Poz1-Tpz1-Ccq1-Pot1 complexes are 
captured through Rap1-Poz1 interaction and it has been suggested that in this conformation 
Ccq1 cannot carry out its recruiting/activating function on telomerase (see section 1.4.3), 
thereby inhibiting telomere extension and causing them to shorten. Hypothetically, the 
inhibition of Ccq1 function on telomerase could be achieved by a conformational change 
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transduced upon bridging of the two shelterin subcomplexes, the double-strand and single-
strand binding halves, by Poz1. Additionally, should fission yeast telomeres also form T-loop 
structures, the DNA ends might fold back in a similar manner observed at human telomeres, 
physically sequestering the DNA ends from telomerase (Miyoshi et al., 2008, Bianchi and 
Shore, 2008). A folding back of the budding yeast telomere had previously been reported by 
Strahl-Bolsinger et al. in 2007. 
 
 
Figure 1.16. A model for telomere length regulation in fission yeast.  
The upper figure represents the situation in the case of long telomeres, the lower the case of short telomeres. At long 
telomeres, many Taz1-Rap1 complexes are bound to the abundant number of telomeric repeats. Due to the resulting high 
concentration of Taz1-Rap1, the Poz1-Tpz1-Ccq1-Pot1 complexes are bound and sequestered. Given this conformation, the 
Ccq1 activating/recruiting function on telomerase is thought to be inhibited. At short telomeres, fewer Taz1-Rap1 complexes 
are present, resulting in free Poz1-Tpz1-Ccq1-Pot1 complexes bound to the 3’ overhang and in this conformation Ccq1 can 
activate/recruit telomerase which in turn lengthens the telomere. Adapted from Bianchi and Shore, 2008. 
 
 
In the case of short telomeres, fewer Taz1-Rap1 molecules are bound, not allowing 
binding and sequestering all available Poz1-Tpz1-Ccq1-Pot1 complexes. In this 
conformation, Ccq1 can carry out its recruiting/activating function on telomerase, thereby 
promoting the extension of the short telomere. Furthermore, should there be T-loop formation 
in fission yeast, the structure would be opened thereby presenting a free DNA-end readily 
accessible by telomerase (Miyoshi et al., 2008, Bianchi and Shore, 2008). 
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1.4.3 Ccq1 and telomerase 
 
The Est proteins (ever-shorter telomeres) are telomerase interacting accessory 
proteins and have been shown to be essential for telomere-lengthening in fission yeast as well 
as in S. cerevisiae and humans. Webb and Zakian showed (2012) that in fission yeast Est1 
and Trt1 association with telomeres is dependent on the shelterin component Ccq1. They 
propose that telomerase recruitment to the telomeres is mediated by the interaction of Est1 
with Ccq1 and that this interaction is required for the subsequent association of Trt1 with the 
telomere. Consistent with this model, another group reported that Ccq1 T93 phosphorylation 
by Tel1 (ATM) and/or Rad3 (ATR) is a critical step in telomerase-telomere association, as 
this phosphorylation is required for Ccq1-Est1-interaction (Moser et al., 2011). 
Phosphorylation of T93 in Ccq1 for telomerase recruitment was reported shortly after also by 
Yamazaki et al. (2012). After the telomerase holoenzyme is recruited to the telomere, the 
interaction of Est1 with the telomerase RNA TER1 is thought to tether the complex to the 
telomere. Webb et al. suggest that after the recruitment of the telomerase holoenzyme, a 
conformational change takes place in the shelterin-complex that makes the end of the 
chromosome accessible to telomeric repeat addition by Trt1. Whether the conformational 
change occurs after recruitment of telomerase, or whether the conformational change (from 
the closed to the open state) needs to take place before Ccq1 becomes active and can recruit 
telomerase (as described in the model in 1.4.2), requires further investigation.  
 
 
1.5 The CST complex 
 
In humans and fission yeast, shelterin is the primary telomere protein complex. In 
recent years an additional telomere-associated complex has been discovered. This complex is 
known as the CST complex and in humans consists of CTC1, STN1 and TEN1 with the later 
two being orthologous to Stn1 and Ten1 from S. cerevisiae (figure 1.17) (Surovtseva et al., 
2009; Miyake et al., 2009; Casteel et al., 2009). In S. cerevisiae, Stn1 and Ten1 assemble 
together with Cdc13 and bind the 3’ overhang while the Rap1-Rif2-Rif1 complex binds to the 
double-strand telomeric repeats (Grandin et al., 2001). Cooperatively, both complexes are 
essential for telomere integrity in S. cerevisiae (Bianchi and Shore, 2008; Giraud-Panis et al., 
2010; Anbalagan et al., 2011). Deletion of any of the CST components leads to C-strand 
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degradation, DNA damage response and cell cycle arrest (Garvik et al., 1995; Grandin et al., 
1997; Grandin et al., 2001).  
 
 
Figure 1.17. Protein-telomere complexes in different species.  
Additionally to them being found at the S. cerevisiae telomeres, Stn1-Ten1 homologues have also been discovered in 
humans and fission yeast. Figure adapted from Longhese et al., 2012. 
 
 
For a long time it was thought that the CST complex was absent in humans because 
the homologues were difficult to detect in the human genome. It was assumed that in humans, 
the CST complex was replaced by POT1 which occupies the single-stranded 3’ overhang. 
Following the discovery of the CST complex in humans (Surovtseva et al., 2009; Miyake et 
al., 2009; Casteel et al., 2009) it has been suggested that multiple protein-telomere complexes 
work in concert in maintaining the chromosome ends (Price et al., 2010). Knockdown of CST 
allows excessive telomerase activity, promoting telomere elongation. This suggests a role in 
restriction of telomerase. In light of the cooperativity of shelterin and CST, it has been shown 
that STN1 interacts with TPP1 (Wan et al., 2009). Given the fact that TPP1 interacts with and 
stimulates telomerase, it has been proposed that STN1 is also involved in telomerase 
regulation, likely in negative regulation (Wang et al., 2007; Xin et al., 2007; Chen et al., 
2012). 
 
In 2007, a CST-like complex was also discovered at the fission yeast telomeres 
(Martin et al., 2007). The proteins spStn1 and spTen1 interact with each other and localize to 
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the telomeric 3’ overhang. However, no interactions between fission yeast shelterin and the 
Stn1-Ten1 complex have been detected to date. It is likely that further interaction partners 
that link the two complexes remain to be discovered. Deletion of either Stn1 or Ten1 leads to 
a phenotype similar to that of potΔ strains: Loss of telomeric DNA is observed with survival 
achieved by chromosome circularization. The crystal structures of Stn1-Ten1 from fission 
yeast, S. cerevisiae and C. tropicalis revealed remarkable conservation amongst each other 
and with the Rpa2-Rpa3 complex (which bind single-strand DNA by means of its OB-folds) 
(Sun et al., 2009; Bochkarev et al., 1999). Thus, the CST complex has been suggested to 
function as a telomere-specific RPA complex (Gao et al., 2007). 
 
In summary, the discovery of the CST complex in organisms besides S. cerevisiae, 
reveals an aspect of telomere regulation that is not restricted to organisms that lack Pot1 
afterall, but that is a more conserved mechanism than previously thought. 
 
 
1.6 Telomere biology and disease 
 
In recent years emerging evidence has been found linking age-related diseases to 
mechanisms of telomere maintenance. The first described telomere-mediated syndrome was 
dyskeratosis congenita (DC), a rare syndrome of premature aging (see Walne et al., 2008 for 
a historical review). DC is thought to be caused by mutations in the gene encoding dyskerin 
which lead to compromised telomerase activity and short telomeres (Mitchell et al., 1999). 
Since then, many more diseases have been attributed to the short telomere defect (Armanios 
and Blackburn, 2012) (table 1.1).  
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Gene First diagnosis Mechanism of telomere shortening Reference 
TERT; TR Familial IPF  Partial loss-of-function Hao et al., 2005; 
Vulliamy et al., 
2001; Armanios et 
al., 2005; 
Yamaguchi et al., 
2005; Alder et al., 
2008; Armanios et 
al., 2007; Tsakiri et 
al., 2007; 
Yamaguchi et al., 
2003; Calado et al., 
2009; Kirwan et al., 
2009; Vulliamy et 
al., 2002; Fogarty et 
al., 2003 
 Sporadic IPF  Haploinsufficiency 
 Aplastic anaemia  
 Autosomal-dominant dyskeratosis 
congenita 
 
 Familial MDS-AML  
DKC1 De novo dyskeratosis congenita  Partial loss-of-function Heiss et al., 1998; 
Mitchell et al., 
1999; Knight et al., 
1999; Yaghmai et 
al., 2000 
 X-linked recessive dyskeratosis congenita  Decreased TR stability and 
biogenesis 
 Hoyeraal-Hreiderasson syndrome  
TINF2 De novo dyskeratosis congenita  Not completely understood Walne et al., 2007; 
Walne et al., 2008; 
Chiang et al., 2004 
 Autosomal-dominant dyskeratosis 
congenita 
 Probably dominant-negative 
mutations 
 Hoyeraal-Hreiderasson syndrome  
 Revesz syndrome  
NOP10 Autosomal-recessive dyskeratosis 
congenita 
Presumed loss of telomerase function Walne et al., 2007 
NHP2 Autosomal-recessive dyskeratosis 
congenita 
Presumed loss of telomerase function Vulliamy et al., 
2008 
TCAB1 Autosomal-recessive dyskeratosis 
congenita 
Impaired TR trafficking; loss-of-function Zhong et al., 2011 
CTC1 Coats plus syndrome Loss-of-function Gu et al., 2012; 
Keller et al., 2012; 
Anderson et al., 
2012; Polvi et al., 
2012 
 Autosomal-recessive dyskeratosis 
congenita 
 
Table 1.1. Disease spectrum and mechanism of telomere shortening in telomere syndromes 
AML, acute myeloid leukaemia; CTC1, conserved telomere protection component 1; DKC1, dyskeratosis congenita 1; IPF, 
idiopathic pulmonary fibrosis; MDS, myelodysplastic syndrome; TCAB1, telomerase Cajal body protein 1; TINF2, TRF1-
interacting nuclear factor 2. Table adapted from Armanios and Blackburn, 2012. 
 
 
 
Furthermore, research in the field of telomere dysfunction has revealed the role of 
telomere regulation in the context of cancer. It has been shown that reactivation of telomerase 
in cells harboring critically short telomeres leads to the acquisition of unlimited proliferative 
capacity as is found in cancer cells (Ding et al. 2012). The current opinions on cancer in 
telomere biology are discussed in the following. 
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1.6.1 A “molecular clock” 
 
While for germ line cells a high proliferative capacity is desired, somatic cells need to 
be limited in their replicative potential. It has been proposed, that the loss of telomeric 
repeats, when reaching a critical telomeric length (~ 3kb), induces a DNA-damage signal that 
results in the exit of the cell cycle and replicative senescence (Campisi, 1997). This lays the 
foundation for a “molecular clock” that determines the replicative life of a cell (Vaziri et al., 
1998). Consequently, cells can only replicate a certain number of times before they settle in a 
state of senescence and seize to proliferate. The fact that telomeres progressively shorten in 
somatic cells comes from the repression of telomerase in this cell type (Allsopp et al., 1995). 
On the other hand telomerase is active in cells of the germinal line which have long telomeres 
(~10kb) ensuring continuous proliferative capacity (Hastie et al., 1990). The importance of 
telomerase expression was most definitively shown by Bodnar et al. who reintroduced 
telomerase into primary human fibroblasts and endothelial cells that lack telomerase activity. 
They found elongated telomeric tracts resulting in a significant increase in their replicative 
life (Bodnar et al., 1998). 
 
 
1.6.2 Telomeres in cell immortalization and cancer 
 
In normal somatic cells telomerase is repressed and telomeres progressively shorten, 
until they reach a critical length where after they enter a state of senescence. The mechanism 
of cell cycle exit in these cells is maintained by signals that activate the pathway of the tumor 
suppressor genes p53 and p16/Rb (Shay et al., 1991). It is thought that inactivation of these 
pathways allows bypassing of replicative senescence and further telomere attrition. This 
process is characterized by a two-stage model of cell growth (see Shay et al., 2011 for a 
recent review): The stage when all checkpoints are intact and regular replicative senescence 
occurs, is referred to as the mortality stage 1 (M1). Upon bypassing M1 by disruption of the 
p53 and/or p16/Rb pathways (caused by endogenous mutations or exogenous mutagens, 
Hollstein et al., 1991, Counter et al., 1992; Rogan et al.,1995), cells proliferate further until 
they reach the crisis stage (M2) (Girardi et al., 1965, Wright et al., 1989) (See also Noble et 
al., 2004). Intriguingly, the crisis stage can act as a line of defense against cancer 
development because genomic instability that arises during this stage and DNA-damage 
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signaling kills off the vast majority of cells. However, rare immortalized clones can arise 
from crisis stage by telomere lengthening through reactivation of telomerase or in the absence 
of telomerase through ALT (“alternative lengthening of telomeres” without the necessity of 
telomerase via inter-telomeric recombination) (Murnane et al., 1994; Dunham et al., 2000). 
Reactivation of telomerase is thought to occur by mutation of additional oncogenes and 
tumor suppressor genes. This is supported by a study that showed that telomerase is active in 
up to 90% of human tumors with no telomerase activity found in any of the somatic tissue 
analyzed (Dhaene et al., 2000).  
 
While the mechanisms linking telomere dysfunction and cancer are complex and 
require more investigations, the progressive understanding of the interplay of telomere 
associated proteins lays the foundation for research on the manipulation of telomerase 
activity as a potential therapeutic target against cancer. Currently, therapeutics directed 
against telomerase have yet to show success in the clinic, thus further underlining the 
importance of gaining as much understanding as we can on the mechanisms involved (see 
Tárkány et al., 2008 for a review). 
 
 
1.7 Aim of this work 
 
The telomerase enzyme adds the telomeric repeats to the ends of linear chromosomal 
DNA, and these in turn recruit and bind a large number of factors that protect telomeres from 
the DNA repair machinery, and maintain telomeric length. Some of these telomeric factors 
form the telomere binding complex known as shelterin. The proteins forming the shelterin 
complex have been shown to be essential for proper telomere maintenance. Here we are 
particularly interested in the molecular details of shelterin architecture and how they function 
in regulating telomeric length. The current models that explain telomere length regulation in 
fission yeast and humans still remain partially speculative and more work needs to be done in 
order to verify their correctness. Our goal is to improve our molecular understanding of 
shelterin components and their interactions through a combination of structural biology and 
in vivo manipulation of fission yeast. 
To date, limited structural information is available on the shelterin proteins. Structures 
determined include the OB1 domain of spPot1 (Lei et al., 2003) and the hPOT1 DNA-
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binding domain (Lei et al., 2004), the structures of the hTRF1 and hTRF2 DNA-binding 
domain (Court et al., 2005) as well as their dimerization domain (TRF-homology domain) in 
complex with a peptide of hTIN2 and hApollo respectively (Chen et al., 2008). Furthermore, 
the structure of the OB domain of hTPP1 has been determined (Wang et al., 2007) as well as 
a fusion construct of the C-terminus of spRap1 bound to a peptide of spTaz1 (Chen et al., 
2011). While for some of the remaining components and domains structure predictions can be 
used, others remain enigmatic. One such poorly characterized protein is Poz1, a fission yeast 
shelterin component that has only recently been identified and supposedly is the human 
functional homolog to TIN2 (Miyoshi et al., 2008). It is the structure and function of Poz1 
around which my PhD-thesis is centered. 
 
The current model for fission yeast length regulation proposes that the shelterin 
complex exists in two different conformations: on short telomeres, an open conformation 
where Taz1-Rap complexes are bound to the double-strand telomeric repeats and Poz1-Tpz1-
Ccq1-Pot1 complexes are bound to the 3’ single-strand overhang. On long telomeres, due to 
the high concentration of Taz1-Rap1, the Poz1-Tpz1-Ccq-Pot1 complexes are bound to Rap1 
thereby forming the closed complex. In the open conformation, Ccq1 has been proposed to 
carry out its recruiting/activating function on telomerase whereas in the closed conformation 
this activity is inhibited. Additionally it is thought that in the closed conformation, the DNA-
end folds back which physically sequesters the 3’ends and prevents them from being 
extended by telomerase. In this model, the Poz1-protein plays a crucial role, as it is the bridge 
between the double-strand and the single-strand binding part of shelterin and based on the 
model this is where the complex opens and closes. 
By solving the structure of spPoz1 in complex with its binding partner spTpz1, we 
anticipated to uncover the molecular architecture of this complex, the function of which we 
aimed to address in vivo through mutation. Through this approach we set out to improve 
current models of telomere homeostasis. 
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2. Material and methods 
 
2.1 Boundary optimization by limited proteolysis and subsequent identification by 
LC/MS 
 
2.1.1 Limited proteolysis of spPoz1
30-249
+Tpz1
360-508
 and “in-gel” protein identification 
 
The protease trypsin was added to spPoz1
30-249
+Tpz1
360-508 
at 10 mg/ml in steps of 
increasing concentration from 0.003 to 3 % in a volume of 20 µl. The reactions were kept on 
ice for 10 minutes, after which the reaction was stopped by adding PMSF 
(phenylmethanesulfonylfluoride) (Sigma) to a final concentration of 5 mM. The samples 
were then immediately boiled at 110 °C for 5 minutes and quickly loaded on SDS-PAGE. 
 
For “in-gel” protein identification, bands were excised from the SDS-PAGE gel and 
subjected to mass-spectroscopy. For generation of peptide fragments, the excised gel pieces 
were digested with trypsin (Promega) at 19 ng/µl overnight at 37°C. The samples were 
analyzed on a MALDI-TOF (Bruker, Ultraflex2) by Daniel Hess and Ragna Sack from the 
FMI protein analysis facility.  
 
 
2.1.2 Identification of co-migrating fragments by size exclusion chromatography 
 
SpPoz1
30-249
+Tpz1
360-508
 is generally stored in
 
50 mM Tris-HCl, 500 mM NaCl and     
0.25 mM TCEP (tris(2-carboxyethyl)phosphine) unless otherwise stated. A volume of 500 µl 
of spPoz1
30-249
+Tpz1
360-508
 at 10mg/ml was incubated with 0.1 % trypsin for 10 minutes on 
ice. The reaction was stopped by adding PMSF to a final concentration of 5 mM where after 
the sample was immediately injected on a SD200 10/300 gelfiltration column (GE 
Healthcare). 
 
 
Chapter 2 – Material and methods  32 
       
 
2.1.3 Boundary identification of Tpz1-fragments by LC/MS 
 
For precise boundary identification in solution we performed liquid chromatography 
coupled to mass spectroscopy (LC/MS) in collaboration with Daniel Hess and Dominique 
Klein from the FMI protein analysis facility. For separation of the fragments in solution, the 
proteolysed sample containing the fragments of interest was injected on a PLRP L50mm 
ID1mm 300A 5 um column (Polymer Laboratories) and run in an acetonitrile gradient on a 
HPLC system (Agilent 1100) coupled to a 4000 Q TRAP LC/MS/MS system (AB Sciex). 
 
 
2.2 Cloning 
 
Plasmids containing cDNA for full-length fission yeast (S. pombe) Tpz1 and Poz1 
were provided by Peter Baumann (Stowers Institute, Kansas City). Poz1
30-249 
was amplified 
from this plasmid by PCR using KOD polymerase (Novagen) and the following primers, and 
the resulting product was inserted into the pNT80e vector (Thomä Lab, His-tag vector 
derived from pColADuet-1, Novagen) by restriction ligation using the Not1 and Kpn1 sites. 
 
Forward primer: 
AAGAATGCGGCCGCGAATCTTCCATTGTGAACGC 
 
Reverse primer: 
CGGGGTACCTCACTAATTAATGTTTGAGGTAA 
 
Tpz1
475-508 
was PCR-amplified using KOD polymerase and the following primers and 
inserted into pNT10e (Thomä Lab, GST-tag vector derived from pGEX, GE) by restriction 
ligation using the Not1 and Kpn1 sites. 
 
Forward primer: 
AAGAATGCGGCCGCAACTCTGAGGCCTGTGAAAT 
 
Reverse primer: 
CGGGGTACCTCATTAGCTTTTGTTTCGAAACT 
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2.3 Mutagenesis 
 
Dimerization and zinc-site mutants of Poz1-Tpz1 where generated by PCR amplifying 
the previously prepared plasmids (see section 2.2) with Phusion High-Fidelity polymerase 
(Finnzymes) and primers containing the appropriate mutations. The dimerization mutant   
Poz1
30-249
_V34E_C37R was generated with the following primers using spPoz1
30-249
 as 
template: 
 
Forward primer: 
TCTTCCATTGAAAACGCCAGGTTACGATAT 
 
Reverse primer: 
AGAAGGTAACTTTTGCGGTCCAATGCTATA 
 
The zinc-site mutant was generated in two steps. First residues C479A and C482A 
were mutated by PCR amplifying Tpz1
475-508 
using the following primers: 
 
Forward primer: 
TCTGAGGCCGCTGAAATGGCTCGGCTTGGG 
 
Reverse primer: 
AGACTCCGGCGACTTTACCGAGCCGAACCC 
 
In a second step the mutation H488A was added using the following primers: 
 
Forward primer: 
CGGCTTGGGCTACCTGCTGGATCATTCTTTGAG 
 
 
Reverse primer: 
GCCGAACCCGATGGACGACCTAGTAAGAAACTC 
 
The template was subsequently digested by Dpn1 (New England Biolabs) for 1 hour 
at 37°C. The mixture was then transformed in DH5α and clones were selected for antibiotic 
resistance on LB-plates. 
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2.4 Protein production 
 
2.4.1 Native protein 
 
Overexpression of spPoz1
30-249
+Tpz1
475-508 
was carried out in the E. coli strain 
BL21(DE3) Rosetta (Novagen). Cultures were grown at 37°C up to an OD600 of 0.6 in Luria 
Bertani medium (LB, Sigma) supplemented with 25 µg/ml kanamycin, 34 µg/ml 
chloramphenicol and 50 µg/ml ampicilin. Expression was induced by addition of isopropyl-ß-
D-thiogalactopyranoside (IPTG) to a final concentration of 0.25 mM. Cultures were grown at 
20°C for an additional 18 hours. Cells were harvested by centrifugation at 2800 g at 4°C for 
15 minutes. Bacterial pellet was resuspended in 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 0.25 
mM TCEP (tris(2-carboxyethyl)phosphine), 1 mM PMSF, containing a protease inhibitor 
cocktail (Roche). Lysis was induced by sonication (Branson sonifier) for 4 minutes. The 
homogenate was clarified by ultra-centrifugation at 185000 g at 4°C for 30 minutes. The 
supernatant was applied to a 25 ml Ni
2+-
chelating gravity flow column (Sigma) equilibrated 
in lysis buffer. Elution was performed using 120 mM imidazole. The eluent was incubated 
overnight at 4°C in the presence of 2 % TEV protease which resulted in efficient removal of 
the His6-tag and GST-tag from Poz1 and Tpz1 respectively. The sample was then diluted to 
50 mM MES pH 6.5, 300 mM NaCl, 0.25 mM TCEP and loaded onto a 20ml Source S ionic 
exchange column (GE Healthcare) equilibrated in 50 mM MES pH 6.5 and 0.25 mM TCEP. 
The complex eluted at a NaCl concentration of 400 mM. The peak fractions were pooled and 
concentrated where after in a final step the sample was applied to a SD200 26/60 gelfiltration 
column (GE Healthcare). The protein purity was assessed by SDS-PAGE. 
 
2.4.2 Selenomethionyl derivative protein 
 
Production of selenomethionyl derivatized spPoz1
30-249
+Tpz1
475-508
 was performed as 
follows: Protein expression was carried out using the same expression plasmid that was used 
for native protein production. 6 L of 1x minimal medium (M9) were prepared with 1 L 
containing 1.6 g KH2PO4, 5.6 g K2HPO4, 0.8 g (NH4)2SO4, 0.2 g citrate and 0.4 g MgSO4. 
The amino acids Ala, Arg, Asp, Cys, Glu, Gly, His, Pro, Ser, Trp, Tyr, Gln and Asn were 
added to 40 mg/L. Ile, Leu, Lys, Phe, Thr and Val were added at 100 mg per 1 L media. 40 
mg of thiamine and thymine each were added to each liter of M9 media. An overnight culture 
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at 37°C in regular LB medium was prepared. Once the M9 media cooled down after 
autoclaving, to each liter of 1x M9 medium glucose was added to a final concentration of 32 
mM. 25 µg/ml kanamycin, 34 µg/ml chloramphenicol and 50 µg/ml ampicilin were added. 
0.05 g of L-selenomethionine was dissolved in 3 ml of sterile water and added to 1 L of M9 
medium. Each liter of M9 medium was inoculated with overnight culture at a dilution of 1:50 
and grown at 37°C to an OD600 of 0.6. Protein production was induced with 0.25 mM IPTG 
and growth continued for another 18 hours at 20°C. After this point, harvesting of the cells, 
sonication and protein purification was carried out following the same procedure as for the 
native protein (see 2.3.1). Due to the lower yield and reduced expression volume the 
gelfiltration step (figure 2.2) was carried out on the smaller SD200 10/300 25 ml gelfiltration 
column (GE). Subsequently the protein purity was assessed by SDS-PAGE. 
 
2.5 Crystallization of spPoz1
30-249
+Tpz1
475-508 
 
Crystallization conditions for native spPoz1
30-249
+Tpz1
475-508 
were sought using 
commercial crystallization screens. Initial crystals were obtained from the Core3 crystal 
screen (Qiagen) in a 96-well sitting drop plate set up by a Phenix crystallization robot (Art 
Robbins). Crystallization conditions were refined in 24-well hanging drop plates (Hampton) 
with 500 µl crystallization solution in the well and 1 µl of protein mixed with 1 µl of mother 
liquor in the hanging drop. 
 
Crystallization conditions for selenomethionyl derivatized were found by trying the 
same condition that worked best for the native protein. Initial crystals were obtained in 24-
well hanging drop plates and further refined. 
 
Best native and selenomethionyl crystals were briefly soaked in a drop containing 
mother liquor as well as 25 % ethylene glycol for cryoprotection and then flash frozen in 
liquid nitrogen in Hampton cryo loops. 
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2.6 Size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS) 
 
For estimation of the molecular mass of spPoz1
30-249 
and spPoz1
30-249
+Tpz1
475-508
 in 
order to determine their oligomeric state, proteins were injected on a SD200 10/300 
gelfiltration column (GE) coupled to a miniDAWN TREOS multiangle-light-scattering 
detector (Wyatt) and an Optilab T-rEX refractive index detector (Wyatt) (experiment 
performed by Manjappa Lingaragu, FMI Basel). A total amount of 200 µg of each sample 
was injected in 50mM HEPES, 200 mM NaCl and 1 mM DTT. 
 
 
2.7 Analytical size exclusion chromatography 
 
For analytical size exclusion chromatography (SEC), a 25 ml SD200 10/300 
gelfiltration column (GE) was equilibrated in 50 mM Tris-HCl pH 8.0, 500 mM NaCl and 
0.25 mM TCEP. 1 mg of each sample, spPoz1
30-249
, spPoz1
30-249
+Tpz1
475-508 
and                                         
spPoz1
30-249_
V34E_C37R+Tpz1
475-508 
was injected onto the column in a total volume of 100 
µl and run at a flow rate of 0.5 ml/min. All runs were performed consecutively in a single day 
with a blank run of equilibration buffer in between each run. 
 
 
2.8 Generating Poz1-Tpz1 fission yeast (S. pombe) mutant strains 
 
2.8.1 Poz1-Tpz1 dimerization mutants 
 
Gene targeting was carried out according to Bähler et al. (1998). Two different Poz1-
Tpz1 dimerization mutants were generated. The first being fulllength Poz1
1-249 
and the second 
being the N-terminally truncated Poz1
30-249
. For each construct, we additionally designed a 
version tagged with the V5-epitope tag (GKPIPNPLLGLDST) for subsequent analysis by 
western blot. The tag was placed C-terminally linked by 6xGly residues. The following 
constructs were designed: 
 
1. spPoz1-WT-V5 
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2. spPoz1-V34E-C37R 
3. spPoz1-V34E-C37R-V5 
4. spPoz1
30-249
 
5. spPoz1
30-249
-V5 
6. spPoz1
30-249
-V34E-C37R 
7. spPoz1
30-249
-V34E-C37R-V5 
 
In a first step, the Poz1 gene was deleted in Schizosaccharomyces pombe strain             
SPB72:h+leu1-32ade6-M216ura4-D18his3-D1 (provided Yukiko Shimada, Bühler Lab, FMI 
Basel). To achieve this, the kanamycin resistance cassette in pFA6a (Bühler Lab, FMI) was 
amplified with oligonucleotides containing 80 base pairs homology to the 5’ and 3’ UTR of 
spPoz1 respectively: 
 
Forward primer: 
ATCTCGTAGACCAACTTACATTGACTTTACCAACTTTTTATACTTTTATCCTTCGTGTATAGATTAG
TTTTTTCCATAAACGGATCCCCGGGTTAATTAA 
 
Reverse primer: 
TAGTTTTAGACTTTTGACCCCTCCAGGAATTTAAAGATACCAAAAATTTATTAATATAAAGAGCTTA
TCGTTATTCGATAGAATTCGAGCTCGTTTAAAC 
 
The amplified product was then transformed in SPB72 according to the LiOAc 
protocol (Okazaki et al., 1990, Kanter-Smoler et al., 1994) and plated on plates containing 
YES-medium and kanamycin antibiotics. Colonies grew after three days. Positive clones 
were determined by PCR and restreaked in such a way that single colonies could be selected 
and restreaked once more on fresh plates. These cells were used for the following steps. From 
these isolated colonies, genomic DNA was extracted by boiling and vortexing a small amount 
of cells picked from the plate in 10 µl 20 mM NaOH.  
 
In a second step, constructs 1-7 were re-inserted in the genome in the position of the 
kanamycin resistance cassette that had been inserted into the genome at the place of poz1 in 
the first step. 
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Spliced Poz1 and Poz1_V34E_C37R where amplified with primers containing PacI 
and AscI restriction sites and subsequently were cloned into pMB22 (provided by Claudia 
Keller and Marc Bühler, FMI Basel) by restriction ligation with PacI and AscI (NEB). This 
vector has a terminator sequence and a nourseothricin (NAT) resistance cassette following 
the AscI restriction site. The primer combinations used for the various constructs are listed in 
table 2.1. Constructs that included a C-terminal V5-tag were amplified with primers 
containing the tag sequence.  
 
Construct Template Forward primer Reverse primer 
1 spPoz11-249 CS1 CS2 
2 spPoz11-249_V34E_C37R CS1 CS3 
3 spPoz11-249_V34E_C37R CS1 CS2 
4 No ligation required, spPoz11-249_pMB22 was used to amplify spPoz130-249 for homologous 
recombination 
5 No ligation required, spPoz11-249-V5_pMB22 was used to amplify spPoz130-249-V5 for homologous 
recombination 
6 No ligation required, spPoz11-249_V34E_C37R_pMB22 was used to amplify spPoz130-249_V34E_C37R  
for homologous recombination 
7 No ligation required, spPoz11-249_V34E_C37R-V5_pMB22 was used to amplify spPoz130-
249_V34E_C37R-V5  for homologous recombination 
Table 2.1. Templates and primers used for cloning into the antibiotic resistance cassette vector. 
 
CS1:  
CCTTAATTAAATGAATGAGAAGATTCGTTC 
 
CS2:  
GGCGCGCCTTAGGTGCTATCCAGGCCCAGCAGCGGGTTCGGAATCGGTTTGCCGCCGCCGCC
GCCGCCATTAATGTTTGAGGTAAGCA 
 
CS3: 
GGCGCGCCCTAATTAATGTTTGAGGTAA 
 
Subsequently, the gene, terminator and NAT resistance were amplified from the 
previously generated plasmids using the primers listed in table 2.2 containing the appropriate 
5’- and 3’ UTR homology sequences.  
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Construct Template Forward primer Reverse primer 
1 spPoz11-249-V5_pMB22 CS4 CS5 
2 spPoz11-249_V34E_C37R_pMB22 CS4 CS5 
3 spPoz11-249_V34E_C37R-V5_pMB22 CS4 CS5 
4 spPoz11-249_pMB22 CS6 CS5 
5 spPoz11-249-V5_pMB22 CS6 CS5 
6 spPoz11-249_V34E_C37R_pMB22 CS7 CS5 
7 spPoz11-249_V34E_C37R-V5_pMB22 CS7 CS5 
Table 2.2. Templates and primers used to amplify the gene and resistance cassette to be integrated into the S. pombe 
genome. 
 
CS4: 
ATCTCGTAGACCAACTTACATTGACTTTACCAACTTTTTATACTTTTATCCTTCGTGTATAGATTAG
TTTTTTCCATAAAATGAATGAGA AGATTCGTTC  
 
CS5: 
TAGTTTTAGACTTTTGACCCCTCCAGGAATTTAAAGATACCAAAAATTTATTAATATAAAGAGCTTA
TCGTTATTCGATAGAATTCGAGCTCGTTTAAAC 
CS6: 
ATCTCGTAGACCAACTTACATTGACTTTACCAACTTTTTATACTTTTATCCTTCGTGTATAGATTAG
TTTTTTCCATAAAATGGAATCTTCCATTGTGAACGC 
 
CS7: 
ATCTCGTAGACCAACTTACATTGACTTTACCAACTTTTTATACTTTTATCCTTCGTGTATAGATTAG
TTTTTTCCATAAAATGGAATCTTCCATTGAAAACGC 
 
 
The resulting products were transformed in the poz1Δ strain generated in the previous 
step. The transformation was plated on YES-medium plates containing NAT antibiotics. First 
colonies appeared after 3-4 days and were restreaked and isolated as described before. From 
isolated single colonies, genomic DNA was extracted by boiling and vortexing a small 
amount of cells picked from the plate in 10 µl 20 mM NaOH. The isolated DNA was used to 
amplify PCR products covering the entire gene, as well as at least 70 base pairs upstream of 
the 5’ homolgous recombination site and covering the 3’ end up to the resistance cassette. 
These amplicons were then sent for DNA sequencing (Novaseq, Novartis Basel sequencing 
service).  
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2.8.2 Zinc binding site mutant strains 
 
Because the tpz1Δ fission yeast strain has been shown to be lethal or grow very slow 
(Miyoshi et al., 2008), we decided to directly replace the C-terminal region of spTpz1 
containing the sites of mutation in the genome, rather than generating an intermediate mutant 
as we did with the Poz1 dimerization mutants (see 2.8.1). Also here we added V5-epitope 
tags to the C-terminus of the protein by including the sequence in the appropriate primers. 
The following spTpz1 constructs were designed: 
 
1. spTpz1
475-508
-V5 
2. spTpz1
475-508
-C482A-H488A 
3. spTpz1
475-508
-C482A-H488A-V5 
 
Tpz1
475-508 
and Tpz1
475-508
-C482A-H488A were amplified from previously generated 
plasmids using the primers listed in table 2.3 containing the PacI and AscI restrictions site 
respectively and restriction ligated into pMB22.  
 
Construct Template Forward primer Reverse primer 
1 spTpz1475-508 CS8 CS10 
2 spTpz1475-508_C482A-H488A CS9 CS11 
3 spTpz1475-508_C482A-H488A-V5 CS9 CS10 
Table 2.3. Templates and primers used for cloning into the antibiotic resistance cassette vector. 
 
CS8: 
CCTTAATTAAAACTCTGAGGCCTGTGAAATG 
 
CS9: 
CCTTAATTAAAACTCTGAGGCCGCTGAAATG 
 
CS10: 
GGCGCGCCTTAGGTGCTATCCAGGCCCAGCAGCGGGTTCGGAATCGGTTTGCCGCCGCCGCC
GCCGCCGCTTTTGTTTCGAAACTCCT 
 
CS11: 
GGCGCGCCTTAGCTTTTGTTTCGAAACTCCT 
 
Chapter 2 – Material and methods  41 
       
 
Gene, terminator and resistance cassette were subsequently amplified using the primers listed 
in table 2.4. The resulting products were transformed and colonies were isolated and their 
DNA sequenced as described in section 2.8.1. 
 
Construct Template Forward primer Reverse primer 
1 spTpz1475-508_pMB22 CS12 CS13 
2 spTpz1475-508_C482A-H488A_pMB22 CS12 CS13 
3 spTpz1475-508_C482A-H488A-V5_pMB22 CS12 CS13 
Table 2.4. Templates and primers used to amplify the gene and resistance cassette to be integrated into the S. pombe 
genome. 
 
CS12: 
CGCTGCAAGAGTTGTATGTTGAGCATCAGAGCAAGAAACGGCGTCTCGAACTATTTCAATTAACA
AATAATCATCAAAAGAACTCTGAGGCCTGTGAAAT 
 
CS13: 
TCACTGTATGTCTGTAACAGTTAACTTCCGTACTTAGTAAAATGTTAGTAAAAAAGGAAGATATGT
GATACAGCAATTGAGAATTCGAGCTCGTTTAAAC 
 
 
2.8.3 SpTpz1-hApollo and spRap1-hTRF2H fusions 
 
In order to replace Poz1 in the S. pombe genome by the structurally similar human shelterin 
components, TRF2H and Apollo, Tpz1
475-508 
was amplified with by PCR where the reverse 
primer contained the DNA sequence for Apollo
495-530 
followed by the V5-tag. The following 
primers were used: 
 
Forward primer: 
CCTTAATTAAACTGAATTCAGGGGTCTAGCA 
 
 
Reverse primer: 
GGCGCGCCTTAGGTGCTATCCAGGCCCAGCAGCGGGTTCGGAATCGGTTTGCCCGAGCCTTTA
TGGTATTTTTCCACTT 
 
This fusion construct was then restriction ligated with PacI and AscI into pMB22. The 
construct was then amplified from this plasmid with primers containing the appropriate 5’ 
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and 3’ 80bp sequence homology such that it would be inserted into the Poz1Δ strain used in 
2.12.1 at the Tpz1 C-terminus with six glycine residues as a linker. 
 
Forward primer: 
GTCGGCTTGGGCTACCTCATGGATCATTCTTTGAGCTATTGCGAGATTGGAAAAAAATAGAGGAG
TTTCGAAACAAAAGCACTGAATTCAGGGGTCTAGC 
 
Reverse primer: 
TCACTGTATGTCTGTAACAGTTAACTTCCGTACTTAGTAAAATGTTAGTAAAAAAGGAAGATATGT
GATACAGCAATTGAGAATTCGAGCTCGTTTAAAC 
 
The resulting strain was then used to insert the Rap1-TRF2H fusion. For this, TRF2
40-
245 
was amplified by PCR with a reverse primer containing the V5-tag and the product was 
inserted by restriction ligation with PacI and AscI into pMB35 (a vector similar to pMB22 
but with a hygromorphine resistance cassette, provided by the Bühler lab). 
 
Forward primer: 
CCTTAATTAAGAGCGCGGCGCGGGGGAGGC 
 
Reverse primer:  
GGCGCGCCTTAGGTGCTATCCAGGCCCAGCAGCGGGTTCGGAATCGGTTTGCCCGAGCCTTTC
AAAGCCTTTTTGGCCA 
The construct was then amplified from this plasmid with primers containing the 
appropriate 5’ and 3’ 80bp sequence homology such that it would be inserted into the Poz1Δ-
Tpz1-Apollo strain at the Rap1 C-terminus with six glycine residues as a linker. 
 
 
Forward primer: 
ACAATTCCTTGAAGCTATGGAATCTACGGGTGGAAGAGTACGAATTGCCATTGCTAAACTACTTT
CAAAACAAACTTCTGAGCGCGGCGCGGGGGAGGC 
 
Reverse primer: 
TATGCATAAAAAGATTCGTAATATTGTACAAGTTTAGGTCTCTTTAGAGAAATAGAATTTGGGCAG
AGATGCTCGGCAATGAATTCGAGCTCGTTTAAAC 
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The resulting strain was then selected for antibiotic resistance against Kan-Nat-Hph. 
Only very few colonies grew on the YES-plates. Nevertheless, a single clone could be 
isolated harboring the correct sequences. 
 
2.9 Telomere length assay 
 
In order to determine the effects of the Poz1 and Tpz1 mutants on telomere 
regulation, the telomere length was determined as described in the following. These 
experiments were performed by Lili Pan in Peter Baumann’s lab at the Stowers Institute, 
Kansas City, USA. 
 
Fission yeast genomic DNA was prepared as follows (Bunch et al., 2005): Frozen 
fission yeast cell pellets at around 5 x 10
8
 cells were thawed, washed in 10ml Z buffer (50 
mM sodium citrate, 50 mM sodium monohydrogen phosphate, 40 mM 
ethylenediaminetetraacetic acid) at pH 7.8 and resuspended in 2 ml Z buffer supplemented 
with 0.5 mg/ml Zymolyase-100T and 2 mM DTT.  The cell suspension was incubated at 
37°C for 1 hour and subsequently sodium dodecyl sulfate was added to 4 % (w/v). Samples 
were incubated at 65°C for 10 minutes.  The volume was increased to 10ml with 5x TE (50 
mM Tris-HCl, pH 8.0, 5 mM ethylenediaminetetraacetic acid) and proteinase K (Sigma) was 
added to 50 µg/ml.  After 1 hour of incubation at 50°C, 3 ml of 5M potassium acetate 
solution was added and samples were incubated on ice for 30 minutes. After removal of the 
precipitate by centrifugation, the clarified supernatant was mixed with 1 volume of 
isopropanol to precipitate nucleic acids.  Samples were kept for 20 minutes and ice and 
subsequently subjected to centrifugation at 10,000 g for 5 minutes. After briefly drying the 
DNA pellets they were resuspended in 0.5 ml 5x TE containing DNase free RNase A (50 
µg/ml).  After incubation at 37°C for 1 hour, organic extraction and ethanol precipitation, 
genomic DNA was resolubilized in 1x TE.  The genomic DNA was then analyzed by 
Southern blotting. 
 
Southern blotting was performed as follows (Baumann and Cech, 2000): 15 – 20 µg 
of genomic DNA was digested for 6 to 8 hours with EcoRI in the appropriate buffers supplied 
by the manufacturer (NEB). Restriction fragments were subsequently loaded onto 1.1 % 
agarose gels and run in 0.5x TBE at 2 V/cm for 16 hours. To confirm equal loading, gels 
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were stained for 30 minutes in ethidium bromide a 1 µg/ml, where after the DNA was 
visualized under UV. DNA was denatured by treatment with sodium hydroxide and then 
transferred onto a nylon membrane (Hybond NX, Amersham) in 10x SSC (1.5 M NaCl, 0.15 
M sodium citrate) by capillary action. Hybridizing probes specific for the telomeric and 
telomere associated sequences (TAS) were created by the same method using gel-purified 
fragments of pNSU70 (Sugawara, 1988). Hybridizations were carried out in Church-Gilbert 
buffer at 65°C (Church and Gilbert, 1984). 
 
 
2.10 Western blot  
 
In order to verify that the Poz1-Tpz1 mutant proteins were expressed in fission yeast, 
western blots with anti-V5 antibody were performed as follows by Lili Pan (Bunch et al., 
2005). 
 
 1x10
8
 fission yeast cells were lysed by vortexing with glass beads (0.5 mm in 
diameter) and in the presence of 10% trichloroacetic acid for 8 minutes at 4°C. Beads were 
washed in 10% trichloroacetic acid, and precipitated proteins were pelleted by centrifugation 
for 2 minutes at 16,000 g. Following an acetone wash, proteins were solubilized in 1 x 
protein sample buffer (1x NuPAGE LDS sample buffer containing 50 mM dithiothreitol and 
2% sodium dodecyl sulfate). Samples were incubated at 75°C for 5 min and subsequently 
centrifuged at 16,000 g for 2 min. Soluble fractions were loaded onto a NuPAGE 4 to 12% 
Bis-Tris gel with 1x MOPS buffer and the gel was run according to the manufacturers 
recommendations. Proteins were then transferred to Protran nitrocellulose membrane in a 
Bio-Rad Mini Trans-Blot cell at 100 V for 1 h. Blocking of the membrane was carried out in 
1x TTBS (20 mM Tris-HCl, pH 7.5, 0.1 % Tween, 137 mM NaCl) plus 5 % nonfat milk. 
Given the V5-tag we added to the Poz1-Tpz1 mutants, the monoclonal anti-V5 (Invitrogen, 
460705) was used at a 1:5000 dilution as primary antibody. Horseradish peroxidase-
conjugated goat anti-mouse (Thermo Scientific, pn31430) was used at 1:5,000 dilution as 
secondary antibody. Bands were detected by ECL2 substrate (Pierce). 
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3. Results – Part I: Fission yeast Poz1-Tpz1 structure solution 
 
 Crystallization of large protein complexes in their fulllength forms is often 
challenging. It is not uncommon to observe low expression levels, aggregation, insufficient 
solubility or poor stability during protein expression. All these factors reduce the likelihood 
of successful crystallization. 
 
In order to overcome this impediment, we optimized the protein boundaries of the 
shelterin components by secondary structure prediction, as well as limited proteolysis. The 
underlying principle of limited proteolysis is the removal of unstructured regions, such as 
flexible loops, by addition of small amounts of protease to the protein. The resisting protein 
should in principle be of a more compact nature, and therefore more likely to result in 
successful crystal formation.  
 
Ultimately, by applying this approach on the different fission yeast shelterin 
components in various combinations, we finally succeeded with Poz1 and Tpz1. The 
optimization procedures are described in the following. 
 
 
3.1 Boundary optimization by limited proteolysis and subsequent identification by 
LC/MS 
 
Poz1 is a 249 amino acid protein with a molecular weight of 30 kDa. The attempt to 
express and purify fulllength Poz1 failed due to the insoluble nature of this protein (figure 
3.1A). Likewise, co-expression together with its binding partners, Rap1 or Tpz1, did not 
alleviate this problem. Following this, we designed a series of constructs of Poz1 based on 
secondary structure prediction (figure 3.2). The most promising of these, was Poz1
30-249
 that 
showed good expression levels and solubility in E.coli (figure 3.1B).  
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Figure 3.1. E. coli expression test of spPoz1.  
SDS-PAGE of Ni2+-affinity pulldowns of A) spPoz11-249 (30 kDa) and B) spPoz130-249 (26 kDa). Lanes 1 show the insoluble 
fraction and lanes 2 the affinity pulldown with Ni2+-resin. 
 
 
Figure 3.2. Structure propensity plot for spPoz11-249.  
The structure propensity secondary structure prediction approach relies on the probability of a given amino acid to form 
secondary structures (α-helix, β-strand and coil). The probability parameters are derived from already determined protein 
structures. The secondary structure states of the neighboring amino acids are also taken into account. Ultimately, a prediction 
is made, on whether a given amino acid sequence is in a folded or unfolded state, allowing the identification of hypothetical 
protein domains (Chou and Fasman, 1974; Garnier et al., 1996). In the structure propensity plot, values >0 predict ordered 
regions of a protein, while values <0 predict disordered regions. The boundary of the most promising construct of Poz1 with 
residues 30-249 is indicated. 
 
Tpz1 is a 508 amino acid protein with a molecular weight of 58 kDa. While it can be 
expressed in its fulllength form in Hi-5 insect cells (Trichopulsia ni, cabbage looper ovary), it 
aggregates when purified by itself as well as in any combination with other shelterin 
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components. Tpz1 is predicted to contain a large unstructured segment in the central part of 
the protein which likely allows Tpz1 to exist in many different conformations due to the 
flexible nature of this region. This in turn is an unwanted characteristic for crystallization. As 
a consequence, we designed a series of constructs of Tpz1 based on secondary structure 
predictions (figure 3.3). 
 
 
Figure 3.3. Structure propensity plot of spTpz11-508.  
Some of the constructs that were designed are highlighted. The C-terminus was of special interest as it contains the Poz1-
binding domain. 
 
Our focus was on a C-terminal construct Tpz1
360-508
, which we showed by affinity 
pulldowns, still harbors the Poz1-binding domain (PBD). Nevertheless, this construct 
remained aggregated/multimerized in complex with Poz1
30-249
. Following this, we decided to 
pursue the limited proteolysis approach to remove unstructured regions that may be causing 
the aggregation. 
 
3.1.1 Limited proteolysis of Poz1
30-249 
+Tpz1
360-508 
 
The protease trypsin was added to Poz1
30-249
+Tpz1
360-508 
in steps of increasing 
concentrations from 0.003 to 3 %. Emerging stable fragments were identified by SDS-PAGE 
(figure 3.4).  
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Figure 3.4. Limited proteolysis experiment with trypsin and Poz130-249 +Tpz1360-508. 
Bands of interest are indicated: Upper arrow: Poz130-249, middle arrow: Tpz1360-508, lower arrow: Putative Tpz1-fragments. 
 
Poz1
30-249 
remained resistant to a protease concentration of up to 3 % trypsin, 
underlining the compact and well structured nature of this construct. Contrariwise, Tpz1
360-508 
showed severe signs of degradation already at low protease concentrations, emphasizing the 
unstructured nature of this protein. At a protease concentration of 0.3 %, the majority of 
Tpz1
360-508
 had been degraded to smaller fragments. In order to answer the question whether 
the low molecular fragments that appeared were originating from Tpz1 degradation, we 
identified the bands from the SDS-PAGE gel by mass-spectroscopy. The results confirmed 
that indeed these fragments are degradation products originating from Tpz1.  
 
 
3.1.2 Identification of co-migrating fragments by size exclusion chromatography 
 
To determine whether any of the low molecular weight fragments that appeared in 
limited proteolysis still bind to Poz1, we repeated the proteolysis experiment in a larger scale 
with 0.1 % trypsin (this being the concentration at which Tpz1 was degraded to smaller 
fragments and Poz1 remained to resist proteolysis (Figure 3.4, lane 6). The reaction was 
stopped by addition of PMSF, followed by immediate analysis of the sample by size-
exclusion chromatography (figure 3.5).  
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A 
 
B 
 
Figure 3.5. Size-exclusion chromatography of the large-scale limited proteolysis experiment: Poz130-249+Tpz1475-508 + 
0.1 % trypsin. 
A) Gelfiltration chromatogram. B) SDS-PAGE: Poz1 and Tpz1 are indicated. The input is in lane (1). Fractions were 
collected in steps of 0.5 ml. Lanes (2) to (13) correspond to elution volumes ranging from 12 to 17 ml. Co-migrating 
fragments are observed at low molecular weight. The Tpz1 fragment of interest at approximately 5 kDa is indicated. The 
fraction in lane (7) was used for boundary identification by LC/MS. 
 
Indeed we found a low molecular weight fragment co-migrating with Poz1
30-249
. The 
band was excised and identified by mass spectroscopy as originating from Tpz1.  
 
 
3.1.3 Boundary identification of Tpz1-fragments by LC/MS 
 
In order to identify the exact boundaries of the co-migrating Tpz1-fragments, we 
applied liquid chromatography coupled to mass spectroscopy (LC/MS). The fragments 
contained in fraction 7 of the gelfiltration (figure 3.5B) could be separated by HPLC and its 
boundaries determined. Ultimately, the precise boundaries of the fragment of interest were 
assigned as Tpz1
 
residues 475-508. 
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3.1.4 Validation of the boundary optimized complex by recombinant expression 
 
The behavior of the Poz1-Tpz1 complex with the optimized protein boundaries 
obtained by LC/MS was tested. A small scale expression test was performed in E. coli and 
the protein complex was purified by pulling on the tag of Tpz1 and subsequently on the tag of 
Poz1     (figure 3.6) 
 
Figure 3.6. Expression test of spPoz130-249+Tpz1475-508. 
Lane (1) shows the insoluble fraction. Lane (2) the affinity pulldown with Glutathion-S-Transferase resin (GST) and lane (3) 
the subsequent pulldown with Ni2+ resin. Because of the similar sizes of 30 kDa for Tpz1 with the GST-tag and 26 kDa for 
His-tagged Poz1, the bands are not distinguishable on the scanned gel. 
 
 
3.1.5 Protein purification of spPoz1
30-249
+Tpz1
475-508
 
 
 In order to obtain pure and sufficient amounts of protein for crystallization trials,                      
Poz1
30-249
+Tpz1
475-508 
was expressed in a larger scale (12 L) in E. coli and purified in three 
chromatographic steps: N
2+
-affinity chromatography, ion exchange chromatography and size-
exclusion chromatography (figure 3.7A). The protein purity was assessed by SDS-PAGE      
(figure 3.7B). A total of 2 mg of pure protein was obtained per 1 L of E. coli culture.  
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Figure 3.7. Protein purification of native spPoz130-249+Tpz1475-508. 
A) Chromatogram and B) SDS-PAGE of the gelfiltration step. The input is in lane (1). Fractions were collected in steps of 4 
ml. Lanes (2) to (9) correspond to elution volumes ranging from 192 to 220 ml. 
 
 
3.1.6 Protein purification of selenomethionyl derivatized spPoz1
30-249
+Tpz1
475-508 
 
 When solving a structure with X-ray crystallography, one must deal with the 
“crystallographic phase problem”. Information about the phase of a reflection cannot be 
determined from the diffraction image, which means the phases need to be determined by 
other means. The phase, however, is required for the calculation of the electron density (see 
Taylor, 2003, for an overview of the phase problem). The simplest method for determining 
the phases is “molecular replacement” (Rossman and Blow, 1962). The principle here is that 
the phases of structure factors from a known protein structure, similar to the one in question, 
are taken and used as initial estimates. The structure factor is a mathematical function 
describing the amplitude and phase of a wave diffracted from crystal. The known protein is 
termed the “phasing model”. It has been shown, that the intensities of the unknown structure 
spTpz1
475-508 
spPoz1
30-249 
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contain enough information to reveal the differences between the phasing model and the 
unknown structure, when using the phases of the known model as initial estimates. The 
phasing model must exert a certain level of similarity. A very low correlation between the two 
proteins may result in very poor solutions produced by molecular replacement algorithms. As 
there were no solved structures in the protein data bank with any apparent similarity to Poz1-
Tpz1 that could have been used for molecular replacement, it was necessary to utilize a 
different method for determining the phases, namely the experimental phasing method of 
multiwavelength anomalous dispersion (MAD) (Hendrickson, 1991). 
 
MAD depends on the characteristic of an atom to absorb X-rays of a specific 
wavelength. The absorption of an element drops sharply just below their characteristic 
emission wavelength Kβ. This sudden drop is called an elements absorption edge. Atoms 
show anomalous scattering if the energy of the X-rays is near the elements absorption edge. 
Elements absorb as well as emit X-rays. When the atom absorbs the energy, it is the re-
emitted, but out of phase with the incident X-ray beam. The energy is also different, because 
some has been used for the transition. This effect is termed anomalous scattering. Data 
collection at and around the absorption edge and comparison of the resulting diffraction 
patterns, allows establishment of the phases of the reflections. 
 
The most commonly used anomalous scatterer for phase determination by MAD is 
selenium. For the incorporation into protein, the sulfur atom in methionine residues is 
replaced by a selenium atom (Hendrickson et al., 1990). Thus protein with selenomethionine 
residues instead of native methionine residues must be produced, purified and crystallized. 
 
The same purification procedure was applied for selenomethionyl derivatized Poz1-
Tpz1 (aside from the expression that was carried out in minimal media containing 
selenomethionine, see section 2.4.2). The complex behaved identical to the native protein, 
except for the lower, but still reasonable expression yield 1 mg of protein per liter of E. coli 
culture (figure 3.8). 
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Figure 3.8. Protein purification of selenomethionyl derivatized spPoz130-249+Tpz1475-508. 
A) Chromatogram and B) SDS-PAGE of the gelfiltration step. The input is in lane (1). Fractions were collected in steps of 
0.5 ml. Lanes (2) to (9) correspond to elution volumes ranging from 12.5 to 16 ml. 
 
 
3.2 Crystallization 
 
For protein structure determination by X-ray crystallography, crystals of Poz1-Tpz1 
were grown and optimized. The successful procedure we applied is described in the following 
section. 
 
3.2.1 Crystallization of native spPoz1
30-249
+Tpz1
475-508 
 
Initial crystals of native Poz1
30-249
+Tpz1
475-508 
grew from solutions containing 30 % 
1,2-propanediol and 0.1 M MES pH 6.5. Rod-shaped crystals grew with various dimensions 
within 2-3 days after mixing. Refinement of these crystals required varying the 1,2-
propanediol concentration, as well as screening pH and protein concentration. This resulted in 
spTpz1
475-508 
spPoz1
30-249 
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single crystals of larger size suitable for X-ray diffraction experiments. Best crystals were 
grown from 14 % 1,2-propanediol, 0.1 M MES pH 6.0 and of a protein concentration of 4.5 
mg/ml. These crystals were flash frozen in liquid nitrogen and mother liquor supplemented 
with 25 % ethylene glycol for cryoprotection and subjected to diffraction tests at the 
synchrotron X-ray beamline (figure 3.9). 
 
 
Figure 3.9. Optimized spPoz130-249+Tpz1475-508 crystals used for native data collection.  
The crystals show a hexagonal base and hexagonal elongated tip. Lower protein concentration (4.5 mg/ml) yielded fewer but 
larger crystals than higher (14 mg/ml) protein concentration. 
 
 
3.2.2 Selenomethionyl crystals 
 
The first step was to try and obtain crystals of selenomethionyl derivative               
Poz1
30-249
+Tpz1
475-508
 in the same crystallization conditions used for the native protein. Small 
and thin needle shaped crystals were obtained in the native crystallization condition 
containing 14 % 1,2-propanediol, 0.1 M MES pH 6.0 and a protein concentration of 4.5 
mg/ml. Lowering the pH to 5.6 yielded fewer but bigger crystals, however the best diffracting 
selenomethionyl crystals were obtained by substituting 1,2-propanediol by the similar 
compound MPD ((4s)-2-methyl-2,4-pentanediol). Well diffracting crystals grew in 6 % 
MPD, 0.1 M MES pH 5.6 and protein at 5 mg/ml (figure 3.10).  
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Figure 3.10. Selenomethionyl derivatized spPoz130-249+Tpz1475-508 crystal. 
Crystal grew in 6 % MPD, 0.1 M MES pH 5.6 and at protein concentration of 5mg/ml within 3 days. 
 
 
3.3 Collection of native diffraction data 
 
Two native data sets were collected. The first on the synchrotron beam line X06SA at 
the SLS (Villigen, Switzerland), which is fitted with a marCCD-225 detector. Data were 
collected for a total rotation range of 180° with an oscillation angle of φ=1.0° per frame and 
an exposure time of 0.5 s (table 3.1). A second data set was collected at the synchrotron 
beam line X10SA at the SLS, which is fitted with a Pilatus 6M detector. 1000 images were 
collected with an oscillation angle of φ=0.25° per frame and an exposure time of 0.25 s. 
Higher resolution was achieved for the second data set (table 3.1). 
 
 
 
 
 
 
 
 
Native data sets  
  Data set 1 Data set 2 
X-ray source X06SA X10SA 
Detector marCCD-225 Pilatus 6M 
Wavelength 1.0 Å 1.0 Å 
Distance 200.0 mm 380.0 mm 
Exposure time 0.5 s 0.25 s 
Oscillation 1.0° 0.25° 
Number of images 200 1000 
Table 3.1. Strategy for the collection of native diffraction data 
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The data images (figure 3.11) were processed using the XDS package (Kabsch, 
2010). Crystals belonged to the space group P3121 of the primitive hexagonal lattice family 
with unit cell dimensions a=66.39 Å, b=66.39 Å, c=126.61 Å, α=β=90° and γ=120°. Data 
processing statistics are given in table 3.2. 
 
 
Figure 3.11. Diffraction pattern of spPoz130-249+Tpz1475-508 crystals. 
A single X-ray diffraction pattern obtained from native Poz1-Tpz1 crystals on the X10SA synchrotron beamline at the SLS. 
Image generated with Adxv (http://www.scripps.edu/~arvai/adxv.html). 
 
 
 
Native data processing statistics  
 Data set 1 Data set 2 
Space group P3121 P3121 
Unit cell a=b=66.10 Å, c=126.30 Å, α=β=90°, 
γ=120° 
a=b=66.39 Å, c=126.61 Å, α=β=90°, 
γ=120° 
Resolution (Å) 11.63-2.40 (2.67-2.60) 10.73-2.40 (2.46-2.40) 
Unique reflections 10311 (739) 13038 (954) 
R-factor (%) 7.9 (69.1) 5.9 (83) 
Multiplicity 11.76 (12.00) 9.00 (9.63) 
Completeness (%) 99.2 (97.9) 98.9 (97.9) 
I/σ (I) 25.50 (4.79) 23.34 (4.28) 
Table 3.2. Statistics for the processing of the high resolution data sets with XDS. 
Values in parenthesis refer to reflections of the outermost resolution shell. 
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Calculation of the Matthew's coefficient (table 3.3) led to the assumption that there is 
one molecule in the asymmetric unit of this crystal form with a solvent content of 53.85 %. 
 
 
 
 
 
 
 
 
 
 
3.4 MAD data collection 
 
The structure of spPoz1
30-249
-Tpz1
475-508 
was resolved using multiwavelength 
anomalous dispersion (MAD) on selenomethionyl derivatives. MAD diffraction data (figure 
3.12) were collected at the SLS beamline X06SA at three wavelengths, at and around the 
absorption edge of selenium. In order to choose wavelengths that give optimal anomalous 
signals, a fluorescence scan (EXAFs=extended X-ray absorption fine structure) was 
performed on the crystal before data collection (figure 3.13). Based on the EXAFs scan the 
following energies were used: E=12.6631 eV (λpeak=0.9791 Å) for the peak corresponding to 
the maximal f''. An energy of E=12.6566 eV (λinflexion=0.9796 Å) was chosen for the edge 
point representing the minimal f', and E=12.7635eV (λremote=0.9714 Å) for a high energy 
remote point. Data for a rotation range of 360° were collected for the peak and inflection. For 
the remote wavelength merely 180° were collected as signs of radiation damage were starting 
to appear. The input parameters for the MAD data collection are listed in table 3.4. 
 
Table 3.3. Calculation of the Matthews coefficient 
Number of molecules 
per asymmetric unit 
Matthews coefficient 
Vm [Da
3/Da] 
Solvent 
content [%] 
P(tot) 
1 2.66 53.85 1.00 
2 1.33 7.70 0.00 
Space group and unit cell dimensions: P3121: a=66.39.4 Å, b=66.39 Å, c= 126.61 Å, 
α=β=90°, γ=120° 
The Matthews coefficient VM is calculated with VM=V/MW*Z*N 
V: Unit cell volume (483285.688 Å3) 
MW: Molecular weight of Poz1-spTpz1 protomer (30241.8 Da) 
N: Number of molecules per asymmetric unit cell 
Z: asymmetric units per unit cell 
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Figure 3.12. Diffraction image of a selenomethionyl derivatized spPoz130-249+Tpz1475-508 crystal. 
A single X-ray diffraction image recorded during MAD data collection on the peak wavelength. Image generated with Adxv 
(http://www.scripps.edu/~arvai/adxv.html). 
 
 
Figure 3.13. Absorption edge plot for selenium. 
EXAFs scan on the selenomethionyl derivatized spPoz130-249+Tpz1475-508 crystal used for MAD data collection. f’ is the real 
and f’’ is the imaginary component of the anomalous signal of selenium. f’ and f’’ are plotted versus the X-ray energy. The 
individual X-ray energies used for data collection are indicated.  
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 Peak Inflection Remote 
X-ray source X06DA X06DA X06DA 
Detector marCCD225 marCCD225 marCCD225 
Detector distance 300 300 300 
Exposure time 1 s 1 s 1 s 
Energy (ε) 12663.1 eV 12656.6 eV 12763.5 eV 
Δφ 1.0 1.0 1.0 
φ 360° 360° 180° 
Table 3.4. Strategy for the collection of MAD data sets 
 
 
3.5 MAD data processing 
 
Data images from selenomethionyl derivatized protein crystals were processed using 
the XDS package (Kabsch, 2010). Crystals belong to the same space group as native crystals 
and data processing statistics are given in table 3.5. Statistics for the anomalous signal are 
given in table 3.6. 
 
X-ray data statistics of MAD data 
 Peak Reflection Remote 
Space group P3121 
a=b=67.03, Å c=124.4 Å α=β=90, γ=120 Unit cell 
Beamline X06DA 
Wavelength (Å) 0.9791 0.9796 0.9714 
Overall resolution (Å) 15.65-3.5 16.10-3.6 16.10-3.6 
Unique Bijvoet’s 7784 7159 7138 
Rsym(I) 11.4 11.2 18.0 
Multiplicity 11.72 11.72 5.84 
Completeness (%) 98.3 98.2 97.9 
I/σ (I) 20.15 22.87 15.16 
Outer resolution shell (Å) 3.59-3.50 3.69-3.60 3.69-3.60 
Unique Bijvoet’s 563 549 543 
Rsym(I) 48.7 30.7 49.7 
Multiplicity 11.8 11.72 5.76 
Completeness (%) 98.8 98.9 97.8 
I/σ (I) 4.03 6.35 4.53 
Table 3.5. Statistics after processing of MAD data with XDS 
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Resolution [Å] S_norm / S_ano 
 Peak Inflection Remote 
9.3 5.61 2.35 3.18 
6.6 4.44 2.00 2.22 
4.5 1.43 0.90 0.97 
3.6 0.91 0.82 0.82 
Table 3.6. Estimation of the anomalous signal with XDS. 
S_norm: mean value of Sigma(I) for acentric reflections assuming Friedel’s law is valid. 
S_ano: mean value of Sigma(I) for acentric reflections assuming Friedel’s law is violated. 
Anomalous scattering contributions to the intensities are indicated by S_norm/S_ano >1 
 
 
 
3.6 Determination of the sub-structure of anomalous scatterers 
 
The positions of the anomalous scatterers in the unit cell were determined with the 
software SOLVE (Terwilliger, T.C. and J. Berendzen, 1999) within the software package 
Phenix (Adams et al., 2010) by inputting the three MAD wavelengths containing the raw, 
unmerged intensities. SOLVE searches for heavy atoms using difference Patterson methods 
and scores potential solutions on the basis of agreement with the Patterson map, the 
difference Fourier map, the presence of solvent and protein regions in a native electron 
density map, and the figure of merit of phasing. Since the calculated Matthew’s coefficient 
predicted a single complex in the asymmetric unit (table 3.3), and spPoz1 contains 8, and 
spTpz1 1 methionine residues, a search for 9 heavy atom positions was carried out using data 
ranging from 20 to 3.6 Å resolution. 7 out of a total of 9 scatterers in the asymmetric unit 
were found. 
 
Given the ambiguity in space group symmetry remaining at that point (P3121 and 
P3221 enantiomeric lattices), both direct and inverted positions of heavy atom clusters were 
assayed in phasing. Visual inspection of the resulting density maps finally revealed this 
crystal form to belong to the space group P3121. 
 
A first electron density map obtained in SOLVE was subsequently subjected to 
maximum likelihood density modification in RESOLVE (Terwilliger, 2000, 2003, 2004) in 
order to improve the quality of the map (table 3.7). We could readily identify several α-
helices and the resulting map allowed model building (figure 3.14A). 
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 Resolution FOM-prior FOM-total 
SOLVE/RESOLVE All 0.46 0.71 
SHARP/SOLOMON All 0.42 0.91 
Table 3.7. Phasing statistics after density modification. 
FOM = Figure of merit. Values are shown for acentric reflections. 
 
 
As a second approach, phases were independently calculated and refined in SHARP 
(Vonrhein et al., 2007) using native data up to 3.5 Å resolution and derivative data to 3.5 Å 
resolution, and by supplying the heavy atom coordinates previously obtained in SOLVE. The 
resulting electron density maps calculated by SHARP had clearly identifiable solvent-protein 
regions and partially interpretable features. Subsequent solvent flattening using the 
SOLOMON procedure (Abrahams and Leslie, 1996) implemented in SHARP assuming a 
solvent content of 53.85 % and phase extension to 2.6 Å furthermore improved the quality of 
the secondary structure features in map (table 3.7) (figure 3.14B). 
 
A
 
B
 
Figure 3.14. Initial electron density map obtained from A) SOLVE/RESOLVE at 3.6 Å maximum resolution and 
 B) SHARP at 2.6 Å maximum resolution. 
2Fobs-Fcalc map is displayed at a contour level of 1.42 σ. A crude skeleton has been generated based on the map in COOT to 
visualize the readily identifiable α-helices. 
 
 
Both electron density maps obtained from SHARP and RESOLVE were of reasonable 
quality to start model building. Combining the two maps for model building yielded optimal 
results. Some features where better identifiable in the map originating from SHARP, 
especially side-chains. On the other hand, flexible regions were better defined in the map 
obtained from RESOLVE. 
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3.7 Model building and refinement 
 
As a first step towards model building, poly-alanine α-helices were manually placed 
in regions of the electron density maps that clearly displayed the typical α-helical appearance 
(COOT, Emsley and Cowtan, 2004; Emsley et al., 2010). These were then progressively 
edited in iterative cycles of model building and refinement. The structure was refined against 
native data ranging from 20 Å to 2.6 Ǻ resolution in REFMAC5 (Murshudov et al., 1997). 
Due to the relatively high resolution of the native data, automatic model building using 
various programs such as RESOLVE, Buccaneer (Cowtan, 2006) and ARP (Lamzin and 
Wilson, 1997, Morris et al., 2003) was attempted. These, however, did not yield any models 
that were more complete than those where α-helices were manually placed. After each cycle 
of model building and refinement, gradually more features appeared in the electron density, 
which allowed the addition of more residues, also in non-secondary structure regions. As 
more details appeared in the maps, some side chains could be built and in combination with 
the knowledge of the positions of the selenomethionine residues, the amino acid sequence of 
secondary structure elements could be determined, as well as the connectivity. Numerous 
cycles of model building and refinement resulted in a near complete model of the Poz1-Tpz1 
complex. It was at this point that a second native data set was obtained with higher resolution, 
such that refinement could be carried out to 2.4 Å. This in turn allowed building some 
features that could not be identified in the previous electron density map. Finally, most of the 
model could be built with the exception of the residues that were not identifiable in the 
electron density, as they are most likely situated in unstructured loops. Solvent atoms were 
built with ARP/wARP (Lamzin and Wilson, 1997). The waters were subsequently visually 
inspected in COOT. The final model contained 178 amino acids in spPoz1 and 29 residues in 
spTpz1 and 22 water molecules. Residues 70-85, 118-121 and 236-249 of spPoz1 could not 
be built. Furthermore, three residues in the N-terminus of spTpz1, 475-477, and two residues 
in the C-terminus, 507-508 are missing in the final model (table 3.8) (see section 4.1 for the 
final structure). The geometry of the structure was analyzed with the program RAMPAGE 
(Lovell et al., 2003) (figure 3.15). 
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Number of residues in favored region (~98.0% 
expected): 201 (97.1%) 
 
 
Number of residues in allowed region (~2.0% 
expected): 6 (2.9%) 
 
 
Number of residues in disallowed region: 0 (0.0%) 
 
Figure 3.15. Analysis of the geometry of the final spPoz130-249+Tpz1475-508 model. 
Ramachandran plot (Ramachandran, 1963) generated with the program RAMPAGE. 
 
 
 
Number of reflections in working / free set 13038 / 2473 
Number of protein residues / solvent molecules 207 / 22 
R-factor / R-free (%) 21.47 / 24.47 
Rmsd bond length (Ǻ) / bond angle (°) 0.010 / 1.10 
Table 3.8. Final refinement statistics of spPoz130-249+Tpz1475-508. 
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4. Results – Part II: Structure and function of fission yeast Poz1-Tpz1 
 
4.1 The crystal structure of spPoz1
30-249 
+ Tpz1
475-508
 
 
The crystal structure of fission yeast (Schizosaccharomyces pombe) Poz1
30-249 
in 
complex with Tpz1
475-508
 has been elucidated at 2.4 Å resolution (figure 4.1) using 
multiwavelength anomalous dispersion (MAD) phases obtained from a selenomethionyl 
variant (see results part I).  
 
 
Figure 4.1: The crystal structure of spPoz130-249+Tpz1475-508.  
Poz1 is colored in wheat, Tpz1 in blue. Secondary structure elements are labeled in Poz1. The regions that were not built due 
to missing electron density are sketched in turquoise. 
 
The complex shows a compact globular, exclusively α-helical structure. Poz130-249 is 
composed of 8 α-helices. The loops containing residues 70-85 connecting α2 and α3 and the 
loop containing residues 118-121 connecting α3 and α4 were not built due to the absence of 
electron density for these regions in the map. Additionally, the final Poz1 residues 236-249 
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were not visible in the electron density, most likely due to the flexible nature of the C-
terminus. Helices α3, α4, α5 and α8 form a four helix bundle. Tpz1 is found locked in 
between α1 and α2 of Poz1. For Tpz1 three residues in the N-terminus, 475-477, and two 
residues in the C-terminus, 507-508 were not visible in the electron density map. 
 
A 
 
B 
 
C 
 
Figure 4.2. Interactions formed between Poz130-249 and Tpz1475-508. 
A) List of residues involved in intermolecular interactions. Hydrogen-bonds are shown by blue lines while non-bonded 
contacts are marked by orange dashed lines. Residues are color coded as follows: Positively charged in light blue, negatively 
charged in red, neutral in green, aliphatic in grey, aromatic in purple, Pro&Gly in orange and cysteine in yellow. Figure was 
generated by PDBsum (Laskowski 2001, http://www.ebi.ac.uk/pdbsum/). B) View of major contacts formed between Poz1 
and Tpz1. Poz1 is shown as a surface model with the surface potential displayed. Stick model of Tpz1 is colored in yellow. 
C) Model of the Poz1 structure with Tpz1 removed. 
 
 
Numerous interactions are formed at the interface of Poz1 and Tpz1, suggesting a 
tight complex (figure 4.2A and B). The interactions include a total of 5 hydrogen bonds and 
122 non-bonded contacts including hydrophobic and ionic interactions as well as base-
stacking. 
Chapter 4 – Part II: Structure and function of fission yeast Poz1-Tpz1 69 
       
 
Major contacts include Phe491 of Tpz1 that inserts in between helix α1 and α2 of 
Poz1 stabilizing α1. Asp497 of Tpz1 forms two hydrogen bonds with Arg102 of Poz1 (not 
visible in figure 4.2B). Lys500 of Tpz1 contacts Glu92 on the surface of Poz1 and Phe504 of 
Tpz1 makes several non-bonded contacts to the hydrophobic surface of Poz1. Trp498 of Tpz1 
is involved in stacking interactions with Tyr63 of Poz1. Furthermore, Arg505 of Tpz1 points 
into a negatively charged pocket of Poz1. 
 
Helix α1 of Poz1 is connected to α2 by an unstructured linker and is held in position 
by the interaction with Tpz1. In the absence of Tpz1-binding (figure 4.2C), we would expect 
α1 to be flexible allowing it to adopt numerous conformations, which poses a likely 
explanation why attempts to crystallize Poz1
30-249 
by itself did not result in crystals. 
 
 
4.2 Structural similarity to human TRF1 and TRF2 
 
Preceding this work, little information was available on Poz1. BLAST (Altschul et al., 
1990) searches as well as Hidden-Markov-Model-(HMM)-based structure prediction (Biegert 
et al, 2006) did not yield any homologous proteins, nor did they reveal any known protein 
domains or sequence motifs. Most likely TIN2 acts as the functional homolog to Poz1 in the 
human shelterin complex. This assumption, however, was made based on the positional 
similarity in the shelterin complex and not on sequence similarity.  
 
Solving the structure of Poz1-Tpz1 allowed us to perform a structure similarity search 
in DALI (Holm and Rosenström, 2010). The DALI server compares a query structure to the 
structures in the protein data bank (Berman, 2000). DALI found two relevant candidate 
structures, which were the “telomere repeat binding factors” TRF1 and TRF2 found in the 
human shelterin complex. The structures of TRF1 and TRF2 that were solved (Fairall et al., 
2001 and Chen et al., 2008) correspond to the TRF-homology domains (TRFH). The TRFH 
domains mediate homodimerization and are structurally almost identical to TRF1 and TRF2. 
We subsequently superimposed our Poz1-Tpz1 structure onto TRF1 and TRF2 (figure 4.3, 
table 4.1 and figure 4.4 for the sequence alignment with secondary structures).  
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Figure 4.3. Superpositions of spPoz130-249-Tpz1475-508 onto hTRF162-268-TIN2256-268 and hTRF286-287-Apollo497-510.  
Poz1 is colored in wheat. Tpz1 in blue, TRF1 in magenta, TIN2 in brown, TRF2 in purple and Apollo in green. A) Poz1-
Tpz1 aligned with TRF1, B) Poz1-Tpz1 and TRF2, C) TRF1 and TRF2 and D) Poz1-Tpz1, TRF1 and TRF2. An orange 
arrow indicates the difference in conformation of α1 in Poz1 compared to α1 in TRF1 and TRF2. 
 
 
 
 
 spPoz130-235 (54-235) hTRF162-268 (115-268) hTRF286-287 (143-273) 
spPoz130-235 (54-235) - 3.171 ( 3.014) 2.768 (2.757) 
hTRF162-268 (115-268) - - 2.057 (2.054) 
hTRF286-287 (143-273) - - - 
Table 4.1. Rmsd (root-mean-square deviation) values [Å] for the superpositions of spPoz1, 
hTRF1 and hTRF2.  
Residues and rmsd values in brackets are for superpositions using boundaries excluding outlier 
regions that are not commonly shared among these structures. Rmsd values were calculated in 
COOT (Emsley et al., 2010). 
 
 
The overall agreement of the Cα-backbones is remarkable. Almost all secondary 
structure elements are present in each structure and only minor positional shifts are observed 
A 
 
B 
 
C 
 
D 
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(figure 4.4). This observation was surprising, as no apparent sequence similarity of Poz1 to 
TRF1 or TRF2 was found.  
In the superpositions of Poz1-Tpz1 with TRF1-TIN2 and TRF2-Apollo (figure 4.3), 
helices α1 to α8 of Poz1 align well with the corresponding helices in the human proteins, 
albeit with some differences in length. Helices α3 and α4 are roughly double the length in 
Poz1 compared to their counterparts in the TRF proteins. The most significant difference 
between the two structures is α1 of Poz1. This helix is found disconnected from the core of 
the protein, while in the TRF proteins this helix is packed closely to the helix bundle (figure 
4.3D). The region analogous to helix α0 of the TRF proteins is not present in the structure of 
Poz1-Tpz1, as it was necessary to truncate the first 29 amino acids of Poz1 due to the 
insolubility of the fulllength protein. Based on secondary structure prediction this region 
might also form an α-helix. Either the truncation of this section is the reason for the different 
conformation of α1 in Poz1 compared to α1 in TRF1 and TRF2, or this helix is naturally 
positioned differently than in the TRF proteins. The region that corresponds to the C-terminal 
helix α9 of TRF1 and TRF2 is not visible in the Poz1 structure, though secondary structure 
prediction suggests that it also forms a helix. Figure 4.3C shows how the structure of TRF1 
and TRF2 superpose, despite the low sequence conservation. 
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Figure 4.4. Sequence alignment with highlighted secondary structure elements.  
The sequence of Poz11-249 was aligned with the sequence of TRF158-268 and TRF284-287 in ClustalW (Larkin et al., 2007). Blue 
cylinders represent α-helices in Poz1, green cylinders α-helices in TRF1 (not shown for TRF2 for simplicity. They are 
almost identical to those in TRF1). Grey cylinders represent regions that are not present in the structure of Poz1 but are 
predicted by PSI-pred (Jones, 1999; Buchan et al., 2010) as α-helices. Red letters show strictly conserved residues, green 
letters show residues that are conserved in an amino acid group and yellow letters represent residues that are conserved 
across groups. 
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4.3 A conserved binding pocket among Poz1, TRF1 and TRF2 
 
Our structure further revealed the location of the Tpz1 binding region in Poz1. From 
the superpositions with the human TRF complexes, we observe that the binding pockets of 
TIN2 in TRF1 and Apollo in TRF2 co-localize to the binding pocket of Tpz1 in Poz1 (figure 
4.5). 
 
Figure 4.5. The binding pockets in spPoz1, hTRF1 and hTRF2. 
Superposition reveals a common binding region found in all three proteins. Poz1 is colored in wheat, TRF1 in magenta and 
TRF2 in purple. 
 
 TRF1 and TRF2 use their binding pockets to bind a number of different telomere 
associated proteins which all share the common binding motif F/Y-X-L-X-P (where X may 
be any amino acid) (Chen et al., 2008). The common binding region suggests that the binding 
pocket of Poz1 may also represent a module for binding different telomeric proteins, although 
to date only Tpz1 is known to bind Poz1 in this location. Assuming that the fission yeast 
binding motif contains similar residues to those found in the human TRFH binding motif, we 
searched for an analogous sequence in the Tpz1 residues bound to Poz1. We found that in the 
binding region, Tpz1 contains residues F-X-L while the remaining residues of the human 
motif are not present. One possibility is that F-X-L is indeed part of a recognition motif and 
the remaining residues are different compared to the human ones. A motif search in the 
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fission yeast genome (Hertz-Fowler et al., 2004. http://old.genedb.org/) for F-X-L expectedly 
returned far too many results, preventing the validation of our hypothesis.  
 
 Upon close inspection of the hypothetical F-X-L motif in our structure (figure 4.6), 
we see that F492 of Tpz1 is positioned differently than their hypothetical counterparts F258 
and Y504 of TIN2 and Apollo, respectively. This may be due to the different conformation of 
helix α1 in Poz1 with which it interacts. Furthermore, given the low sequence similarity of 
Poz1 and the TRF proteins, it is not surprising to find differences in the amino acids involved 
in the binding pocket.  L494 superimposes with the position of F/Y. Residues W498 and 
K500 of Tpz1 superimpose with the conserved motif residues L260
TRF2
/L506
Apollo
 and 
P262
TRF2
/P508
Apollo
.  
 
 
 
Figure 4.6: Molecular details of the substrates in the binding clefts.  
Tpz1 is in blue, TIN2 in brown, Apollo in green. The residues that form the F/Y-X-L-X-P recognition motif in TIN2 and 
Apollo are shown as sticks. Residues that could be part of a motif and share the sequence with the human motif in Tpz1 and 
are shown in blue, residues in Tpz1 that align with the human motif but differ in sequence are in red. 
 
 From the superposition a hypothetical motif F-X-L-X-X-X-W-X-K was derived. A 
search for this motif in the yeast genome returned two results, midasin and Cwf5. Given the 
fact that F492 of the hypothetical motif is positioned at a larger distance from the binding 
pocket compared to F258 in TIN2 and Y504 in Apollo, we speculated that this residue might 
not be part of the motif in fission yeast, and performed another motif search excluding this 
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region (L-X-X-X-W-X-K). This search returned a total number of 127 proteins with a variety 
of functions. The most interesting finding was spTaf1, also known as Taz1 interacting factor 
1 (Ueno et al, 2001). Taf1 as well as other candidates need to be further examined to 
determine whether they play a role at the telomeres. 
 
 
4.4 Oligomeric state of Poz1-Tpz1 
 
The structure of Poz1-Tpz1 revealed a remarkable similarity to the human shelterin 
components TRF1 and TRF2. The structures of TRF1 and TRF2 that had been solved, are the 
TRF-homology domains (TRFH), which in TRF1 and TRF2 are responsible for dimerization. 
TRF1 with TIN2 and TRF2 with Apollo form heterotetrameric arrangements. This finding 
lead to the hypothesis, that Poz1 like TRFH, also functions as a module for dimerization in 
the fission yeast shelterin complex. 
 
 
4.4.1 Arrangement of Poz1-Tpz1 in the crystal lattice – The heterotetramer hypothesis 
 
As an initial step, we analyzed the arrangement of the Poz1-Tpz1 molecules in the 
crystal lattice in an attempt to identify a hypothetical heterotetrameric composition. Should 
the complex indeed form heterotetramers, we would expect to observe such an arrangement 
in the crystal. 
 
Visual inspection showed that throughout the P3121 crystal lattice there are two Poz1-
Tpz1 monomers that come together in a head-to-head manner in the region of the Poz1 N-
terminus and the bound Tpz1 fragment. This could indeed represent a hypothetical 
heterotetrameric arrangement (figure 4.7). 
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Figure 4.7. The P3121 crystal lattice of the spPoz1-Tpz1 crystals used for structure solution. 
Two hypothetical heterotetramers are highlighted in the crystal lattice. One heterotetramer is composed of a Poz1-Tpz1 
protomer A colored in dark red and a protomer B colored in light red. The protomers of a second heterotetramer are colored 
in dark yellow and light yellow. The heterotetramerization interfaces are indicated by blue dashed lines. 
 
 
In a next step we submitted the structure of Poz1-Tpz1 to the PDBePISA server 
(Krissinel and Henrick, 2007) which analyzes macromolecular interfaces and performs 
prediction of probable quaternary structures. PISA returned a hypothetical stable 
heterotetrameric arrangement composed of two Poz1 and two Tpz1 molecules (figure 4.8), 
which corresponded to the heterotetramer we had suggested from visual inspection of the 
crystal lattice.  
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Figure 4.8. Stable spPoz1-Tpz1 heterotetramer as predicted by PISA and as found in the crystal lattice. 
Helices forming major contacts to the opposite protomer are labeled. The interface boundary is indicated by a blue dashed 
line. 
 
 
In this hypothetical heterotetramer, the interface is formed by α1 and α2 of Poz1 in 
each protomer. Following this, we set out to investigate whether there are any similarities of 
this architecture to the heterotetrameric arrangements found in TRF1 and TRF2. To examine 
this, the predicted heterotetrameric model of Poz1-Tpz1 was superimposed onto the TRF1 
and TRF2 heterotetramers (figure 4.9) (for simplicity only the superposition with TRF1-
TIN2 is shown as the superposition with TRF2-Apollo returned an identical result). 
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Figure 4.9. Comparison of the spPoz1-Tpz1 heterotetramer with the hTRF1-TIN2 heterotetramer. 
Poz1 and Tpz1 are colored in wheat and blue, TRF1 and TIN2 in magenta and brown respectively. A) Superposition of 
Poz1-Tpz1 and TRF1-TIN2. The orange line represents a common divider between the protomers in each complex. B) 
Schematic representation of the protomer arrangement in the heterotetramer. 
 
  
Of interest, The Cα-backbones of protomers A superimposed well as expected, while 
the second protomers B did not seem to structurally align. After close inspection of protomers 
B, it became clear that the disagreement arises from the fact that the Poz1-Tpz1 subunit B is 
rotated by 180° with respect to protomer B of TRF1. In the Poz1-Tpz1 heterotetramers, the 
protomers are not mirrored as in TRF1 and TRF2, however, are rather related by a 180° 
rotation around the heterotetramer interface (figure 4.9B). Besides this 180° rotation, we 
found that the heterotetrameric arrangements are similar and a common boundary between 
the protomers of Poz1-Tpz1 and TRF1-TIN2 can be observed (figure 4.9A). 
 
Effectively, α-helix α1 in Poz1-Tpz1, which makes the major contributions to the 
heterotetramerization interface, also plays a role in forming the interface in the TRF 
complexes (figure 4.10). Helix α0 in the TRF proteins is also part of the multimerization 
interface. This helix is absent in our Poz1-Tpz1 structure, because in order to obtain a soluble 
protein, residues 1-29 in Poz1 corresponding to α0 in TRF were removed. Based on structure 
prediction, α0 is also present in Poz1. Thus, as in TRF, it is likely to be involved at the 
heterotetramerization interface. 
 
Chapter 4 – Part II: Structure and function of fission yeast Poz1-Tpz1 79 
       
 
In TRF, a short C-terminal helix α9 is also found at the heterotetramerization 
interface. In Poz1, this region has been predicted to form a short helix, however, we were not 
able to find any electron density for this part of the protein. This could be explained by the 
fact that the N-terminal helix of Poz1 was removed: In the TRF-heterotetramer, the N-
terminal helix α0 interacts with the C-terminal helix α9 of the other monomer, keeping it 
packed close to the core of the protein (figure 4.10B). Possibly, this is also the case in Poz1, 
however, upon removal of the N-terminal helix, the C-terminal helix is no longer bound to 
the core and therefore inherits flexibility because it is merely connected to α8 via a flexible 
linker (figure 4.10A). Thus, due to the high degree of flexibility we fail to identify this region 
in the electron density. 
 
Additionally, helix α2 in Poz1 is also part of the interface, whereas in TRF this helix 
is not involved. Overall, the observed differences between the heterotetramerization 
interfaces may be due to the N-terminal truncation of Poz1.  On the other hand, it is also 
possible that the interfaces are intrinsically different. In any case, these results strengthen the 
likelihood of heterotetramerization in Poz1-Tpz1. 
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Figure 4.10. Overview of secondary structure elements involved at the heterotetramerization interface. 
A) Poz1-Tpz1 in wheat and blue. A hypothetical position of α0 in the Poz1-Tpz1 heterotetramer is indicated in orange. In 
this conformation, α0 and α9 from another protomer could interact as α0 and α9 in TRF1 and TRF2 B) TRF1-TIN2 in 
magenta and brown C) TRF2-Apollo in purple and green. α-helices colored in red represent those that form interactions with 
the opposing molecule. A dashed blue line represents the boundary between protomers. 
 
 
4.4.2 Oligomeric state of Poz1-Tpz1 in solution 
 
In order to validate our heterotetramerization hypothesis, we designed a mutant 
complex in which the hypothetical multimerization interface observed in the crystal lattice 
was disrupted. Subsequently, the mutant complex was compare to the wildtype protein in 
size-exclusion chromatography (SEC). In SEC, proteins are separated based on their 
molecular weight. Larger proteins elute fast while smaller proteins get delayed in the resin 
matrix and elute later. Thus, the transition from a multimeric to a monomeric complex can be 
observed by a shift of the UV-peak to a lower elution volume. 
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4.4.2.1 The Poz1-Tpz1 heterotetramerization mutant 
 
From analysis of the heterotetramerization interface in the Poz1-Tpz1 lattice (figure 
4.8), we observed that most interactions are formed between helices α1 from the two 
protomers. Following this, mutations in helix α1 were introduced, such that two residues with 
the same charge are positioned closely opposite each other, which would lead to a charge 
mediated repulsion of the helices and in turn disruption of the heterotetramerization interface. 
In order to achieve this, residues Val34 and Cys37 in Poz1 were mutated to Glu34 and 
Arg37, respectively. This generated two negative and two positive charges facing each other 
in close proximity in the potential heterotetramer (figure 4.11). These mutants were 
subsequently subjected to size- exclusion chromatography and light scattering for analysis of 
their oligomeric state. 
 
 
Figure 4.11. Close-up view of the Poz1-Tpz1 heterotetramerization interface. 
Helices α1 form the majority of interactions at the heterotetramerization interface. The residues in α1 that are expected to 
disrupt heterotetramerization upon mutation are represented as sticks in the model. 
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4.4.2.2 Analytical size-exclusion chromatography 
 
By analytical size-exclusion chromatography (SEC), we anticipated to observe shifts 
between the elution volumes between Poz1
30-249
, Poz1
30-249
+Tpz1
475-508 
and the 
heterotetramerization mutant Poz1
30-249
_V34E_C37R+Tpz1
475-508
. 
 
SEC of Poz1
30-249 
reported an elution volume of 15.1ml on a SD200 gelfiltration 
column (figure 4.12). Based on the calibration run on this gelfiltration column, this elution 
volume corresponds to the molecular weight of Poz1
30-249
 as a monomer.  
 
 
Figure 4.12. Size-exclusion chromatography for proving the heterotetramerization hypothesis.  
The chromatograms of the three performed chromatography runs were overlaid to visualize the shifts in elution volume. 
Monomeric Poz130-249 wildtype (WT) elutes at similar volume as Poz130-249_V34E-C37E+Tpz1475-508, while wildtype    
Poz130-249+Tpz1475-508 elutes at significantly higher molecular weight, indicating dimer formation. 
 
 
Subsequent injection of Poz1
30-249
+Tpz1
475-508
 returned an elution volume of 14ml, 
which was a significant shift towards higher molecular weight and higher than for a Poz1-
Tpz1 monomer. Based on the elution volume, the estimated molecular mass corresponded to 
a Poz1-Tpz1 heterotetramer. In order to confidently assign the shift to heterotetramerization 
and not solely to the addition of Tpz1
475-508
, a third SEC run with the heterotetramerization 
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mutant was performed. In gelfiltration, the heterotetramerization mutant                        
Poz1
30-249
_V34E_C37R+Tpz1
475-508 
reported an elution volume of 14.9ml which was 
minimally lower than the elution volume of Poz1
30-249
. This agreed with monomeric Poz1 
now bound to a 34 amino acid Tpz1-fragment. However, the peak for the mutant was shifted 
to significantly higher elution volume compared to the wildtype Poz1-Tpz1 complex, 
implying that the wildtype complex is indeed a heterotetramer and that the mutant is not due 
to disrupted heterotetramerization. 
 
These results demonstrate that in the absence of Tpz1
475-508
, Poz1
30-249 
is monomeric 
and upon binding to Tpz1 the complex becomes heterotetrameric. Subsequently, when 
introducing mutations into the heterotetramerization interface, the complex becomes 
heterodimeric (meaning one Poz1 bound to one Tpz1). These results confirm the 
heterotetramerization hypothesis in solution. To address the question whether 
heterotetramerization of Poz1-Tpz1 is relevant in vivo, we designed a number of mutant 
fission yeast strains and monitored telomere length regulation (see section 4.4.3). 
 
 
4.4.2.3 SEC-MALS with Poz1-Tpz1 heterotetramerization mutant 
 
In order to reinforce the results obtained by SEC, we performed size-exclusion 
chromatography coupled to multi-angle-light-scattering (SEC-MALS) to determine more 
precise masses for the complexes. Running Poz1
30-249 
by itself on SEC-MALS gave an 
approximate molecular weight of 26 kDa which was in good agreement with the calculated 
theoretical mass of 26 kDa, further confirming its monomeric state (figure 4.13). In a second 
run,                Poz1
30-249
+Tpz1
475-508
 was injected and returned a mass of 47 kDa which falls 
short of the calculated heterotetrameric mass of 60 kDa, but at the same time was a higher 
mass than for monomeric Poz1-Tpz1 (30 kDa). A possible explanation is that               
Poz1
30-249
+Tpz1
475-508 
occurs in equilibrium of the heterotetrameric and the monomeric form. 
The peaks for the monomer at 30 kDa and the heterotetramer at 60 kDa are overlapping, 
making it difficult to distinguish them and leading to an average peak at 47 kDa.  
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Figure 4.13. Chromatograms of the SEC-MALS experiment. 
For A) Poz130-249 a molecular mass of 26kDa was reported and for B) Poz130-249_V34E_C37R+Tpz1475-508 a molecular mass 
of 47kDa. 
 
We suggest that due to the 29 amino acid N-terminal truncation in Poz1 we may have 
destabilized the heterotetramerization interface compared to the fulllength protein. After 
introduction of the heterotetramerization disrupting mutations, the heterotetrameric form is 
then finally completely eliminated. This goes in line with the in vivo experiments in fission 
yeast where the Poz1Δ1-29 strain showed slight telomere deregulation, possibly due to 
partial, but not complete disruption of heterotetramerization (see section 4.4.3). We 
hypothesize that for fulllength Poz1 we would observe 100% of the heterotetrameric form in 
SEC-MALS, an experiment that has yet to be performed but has proven difficult because of 
the poor behavior of fulllength Poz1 in protein purification (see section 3.1). 
 
Ultimately, the combination of SEC and SEC-MALS has revealed that in solution 
Poz1 by itself occurs monomeric and that binding of Tpz1 induces heterotetramerization of 
the complex. 
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4.4.3 Poz1-Tpz1 heterotetramerization in vivo 
 
To determine whether heterotetramerization of Poz1-Tpz1 exists in vivo, the length of 
the telomeric repeats of the heterotetramerization disruption mutant was compared to that of 
wildtype fission yeast cells. As previously described by Miyoshi et al. (2008), Poz1Δ strains 
show strongly extended telomeric length compared to wild type cells. When introducing the 
charge repulsion mutations that disrupted heterotetramerization in vitro into the fission yeast 
genome, we observed severe telomere elongation, similar to what is observed in Poz1Δ cells 
(figure 4.14).  
 
Figure 4.14. Telomere length assay for Poz1-Tpz1 heterotetramerization mutants. 
Telomeres were analyzed at two time points: After 0 and after 5 restreaks in order to allow the telomere length to equilibrate. 
The Poz1Δ strain shows long telomeres (lane 2) compared to the wildtype strain. The Poz1 heterotetramerization mutant 
shows similarly long telomeres (lanes 7-8). Poz1 lacking the 29 N-terminal amino acids shows mildly elongated telomeres 
(lanes 11-12). After introduction of the heterotetramerization disrupting mutations, Poz1Δ1-29 also shows severe telomere 
elongation (lanes 15-16). V5-tagged versions were designed for protein expression analysis by western blot. The V5-tag 
seems to have no effect on telomere length except in the case of the Poz1Δ1-29 strain: Telomeres are elongated more 
strongly, almost as severely as in the Poz1Δ strain. This could be due to further destabilization of heterotetramerization 
because of the close proximity of the tag to the heterotetramerization interface. 
This indicated that indeed Poz1-Tpz1 exists as heterotetramers in vivo and that upon 
disruption of heterotetramerization, shelterin function is disturbed. The expression of the 
mutant proteins was verified by western blot (figure 4.15). 
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Figure 4.15. Western-blot for the Poz1-Tpz1 heterotetramerization mutants. 
V5-tagged Poz1 is visible on the western blot. All bands are found at the expected sizes: (1) and (2) 31 kDa, (3) and (4) 27 
kDa. The expression levels are not affected by the mutations (1, 4) and the N-terminal Poz1 truncation (3, 4) compared to the 
wildtype protein (1). 
 
In order to assess whether the N-terminally truncated Poz1
30-249 
can retain its function, 
we determined the telomeric length and found slightly elongated telomeres compared to 
wildtype cells (figure 4.14). When comparing the heterotetramerization interfaces of the TRF 
proteins and Poz1-Tpz1, we found the truncated N-terminal region of Poz1 (residues 1-29), in 
TRF corresponds to a helix that makes major contacts at the heterotetramerization interface. 
In Poz1, that sequence region has also been predicted to form a helix and given the highly 
conserved structural architecture of Poz1 and TRF1 and TRF2, it is highly probable that this 
region is also involved at the heterotetramerization interface of Poz1-Tpz1. Due to the 
missing helix in Poz1Δ1-29, there possibly is a slight destabilization of the 
heterotetramerization compared to the wildtype and this could explain why we observe 
slightly longer telomeres. Once the heterotetramerization disrupting mutations are introduced 
in Poz1Δ1-29, yet again we observed very long telomeres as in Poz1Δ. From this we 
conclude that even with its missing N-terminal region, Poz1Δ1-29 allows 
heterotetramerization in vivo. However, possibly a less tight complex is formed leading to the 
impaired, but not the fully deficient telomere length regulation observed when the 
heterotetramerization disrupting mutations are introduced. 
Concluding, we discovered that Poz1-Tpz1 forms a heterotetrameric assembly in vitro 
as well as in vivo. Furthermore, these results show that multimerization of Poz1-Tpz1 is an 
essential function of this complex, as disruption of the protein-protein interactions leads to 
severe telomere regulation defects. 
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4.5 Zinc binding by Poz1-Tpz1 
 
4.5.1 Modeling the zinc ion in the Poz1-Tpz1 structure 
 
During the refinement of the Poz1-Tpz1 structure, we repeatedly encountered a large 
patch of positive electron density in the Fo-Fc difference map at a contour level of 1.5σ in an 
area at the interface between Poz1 and Tpz1 (figure 4.16). Despite testing many different 
conformations of the protein backbone and side chains, we could not satisfy the positive 
electron density. 
 
Figure 4.16. View of the electron density at the interface of Poz1 and Tpz1. 
The 2Fo-Fc electron density is shown as a purple mesh. Red mesh indicates negative electron density in the Fo-Fc difference 
map, while green mesh indicates positive electron density. (Figure was generated in COOT, Emsley et al., 2010. Contour 
level is at 1.5σ). 
 
 
After closer inspection of the amino acid composition surrounding the positive 
electron density, the close proximity of two histidine and two cysteine residues became 
apparent. These residues are found in many proteins coordinating metal ions. Following this, 
we attempted to model a zinc ion into the positive electron density. After several steps of 
model building and refinement, the zinc atom could be correctly placed and coordinated by 
two histidine residues and two cysteine residues with ionic bond lengths that agree well with 
the ionic bonds in zinc binding sites of other proteins (figure 4.17).  
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Figure 4.17. Zn2+-ion coordinated at the interface of Poz1 and Tpz1. 
A) Position of the zinc ion in the overall structure. Poz1 is colored in wheat and Tpz1 in blue. B) Close-up view of the 
refined electron density at the zinc-coordination site. C) Schematic representation of the Zn
2+
-ion coordination (Figure 
generated by PDBsum, Laskowski, 2001). 
 
 
In order to verify that a zinc ion rather than any other metal ion is bound, we carried 
out a fluorescence scan (EXAFs) across the absorption edge of zinc at the synchrotron 
beamline (figure 4.18). Based on the obtained absorption edge plot for zinc, we collected 
diffraction data at the peak wavelength (table 4.2). The anomalous scattering contribution 
was subsequently determined after processing with XDS. We observed a significant 
anomalous signal (table 4.3) which together with the expected absorption edge plot was 
evidence that a zinc ion indeed is bound to the complex. 
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Figure 4.18. EXAFs scan over the absorption edge of zinc performed on a Poz130-249+Tpz1475-508 crystal.  
f’ is the real and f’’ is the imaginary component of the anomalous signal of zinc. f’ and f’’ are plotted versus the X-ray 
energy. 
 
 
Resolution [Å] S_norm/S_ano (peak) 
8.18 2.468 
5.84 3.248 
4.78 2.235 
4.15 1.536 
3.71 1.11 
Table 4.3. Estimation of anomalous signal with XDS.  
 
Interestingly, the zinc ion is bound at the interface between Poz1 and Tpz1. The metal 
ion is coordinated by residue His49 provided by Poz1 and residues Cys479, Cys482 and 
His488 provided by Tpz1 (figure 4.17C). 
Zn-site data set 
  Data set 2 
X-ray source X10SA 
Detector Pilatus 6M 
Wavelength 1.2825Å 
Distance 400.0mm 
Exposure time 0.25s 
Oscillation 0.25° 
Number of images 1600 
Table 4.2. Strategy for the collection of the Zn-site data set 
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Taken together, we have shown that Poz1-Tpz1 binds a zinc ion immediately at the 
protein-protein interaction interface. However, the function of the coordinating Zn
2+
 ion 
remains unclear. It may play a structural role for complex integrity and assembly or it may 
have a regulatory role.  
 
 
4.5.2 Functional role of the bound zinc ion 
 
There is no zinc present in the crystallization conditions. It therefore most likely 
originates from the expression host. To address whether zinc binding is essential for protein 
expression, folding and complex formation, we designed a mutant of the Poz1
30-249
+Tpz1
475-
508 
complex where metal ion coordination is disrupted. We mutated residues Cys479, Cys482 
and His488 of Tpz1 to alanine residues, which would confidently disrupt the binding of zinc. 
Subsequently, we expressed the mutant variant of the Poz1-Tpz1 complex in E. coli, and 
pulled down the protein by Ni
2+
- and GST-affinity and assessed the protein on SDS-PAGE 
(figure 4.19).  
 
 
A
 
B 
 
Figure 4.19. E. coli expression test and affinity pulldown of the zinc-site mutant.  
Poz1 is N-terminally His-tagged while Tpz1 is GST-tagged. On SDS-PAGE, A) the mutant complex (2, 3) shows no 
difference compared to the B) wildtype complex (2, 3). 
 
 
The Tpz1 zinc site mutant formed a complex with Poz1 that behaved identically as the 
wildtype proteins. Therefore we conclude that the binding of zinc is not required for 
expression and complex formation in solution. The zinc site is located at close proximity to 
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the Poz1-Tpz1 heterotetramerization interface. Possibly, failure to bind zinc interferes with 
the formation of the heterotetramer. Conformational changes could occur in the secondary 
structure elements involved in the interface no longer allowing heterotetramerization.  
 
In order to test this hypothesis in gelfiltration, I expressed and purified the zinc site 
mutant Poz1-Tpz1 complex. While the expression level was good and I could readily pull 
down the complex in Ni
2+-
affinity chromatography, the protein subsequently precipitated, 
leaving no material for size-exclusion chromatography. 
 
Given the above findings, I propose that the failure to bind zinc interferes with the 
structural integrity of the complex, thereby reducing its solubility. Furthermore, 
heterotetramerization could be impaired, but this remains to be validated. These findings do 
not exclude that the binding of zinc has additional roles, for example as part of a regulation 
mechanism. To address the question whether the zinc site has any relevance in vivo, we 
determined the effects of zinc site disruption on telomere length regulation in fission yeast 
cells. 
 
 
4.5.3 Zinc atom coordination in vivo 
 
To investigate the relevance of zinc coordination by Poz1-Tpz1 in vivo, the zinc site 
disrupting mutations, C482A and H488A, were introduced into a fission yeast strain and the 
telomeric length compared to the wild type strain was evaluated (figure 4.20) (Due to 
technical reasons a double mutant was chosen as opposed to the triple mutant described in 
4.5.2). The mutant strain showed elongated telomeres, similar to the telomere length of the 
Poz1Δ strain. This result showed that the coordination of the zinc ion is essential in vivo. 
However, whether the 2-fold reduced expression of Tpz1_C482A_H488A observed by 
western blot has an effect on telomere length needs to be further investigated (figure 4.21). 
Firstly the experiment needs to be repeated to determine whether the difference is real, 
secondly mutations of Cys479, Cys482 and His488 to different residues (for example Arg) 
could be tried that disrupt zinc binding but do not change the expression level.  
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Figure 4.20. Telomere length assay for Tpz1 zinc-site mutants. 
Telomeres were analyzed at two time points: After 0 and after 5 restreaks. Lane (1) shows telomere length for the wildtype 
strain, lane (2) shows telomere length for the Poz1Δ strain. The strain expressing Tpz1 with the disrupted zinc site shows 
telomere elongation (6-7). Strains with V5-tag were designed for subsequent expression level analysis by western blot. 
In summary, as in in vitro, failure to bind zinc impairs the integrity of the Poz1-Tpz1 
complex in vivo. Given the observed telomere elongation, it is possible that conformational 
changes in the zinc site mutant lead to impaired multimerization, which in turn leads to the 
same phenotype we saw for the heterotetramerization mutant.  
 
 
Figure 4.21. Western-blot for the Tpz1 zinc site mutant. 
V5-tagged Tpz1 is visible on the western blot. The bands are found at the expected sizes: 58 kDa for (1) and (2). The 
expression levels of the mutant protein (2) are 2-fold reduced compare to wildtype (1). 
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4.6. The function of Poz1 as a molecular bridge 
 
Poz1 bridges the double-strand and the single-strand binding halves of the shelterin 
complex. Based on the data presented in this work, it does so by linking a Rap1 dimer to two 
Tpz1 molecules in a dimeric manner. We were wondering whether Poz1 has any other 
functions besides acting as a “molecular-bridge” between Rap1-Taz1 and Tpz1-Ccq1-Pot1. 
 
To examine this, we set out to construct a mutant fission yeast strain where the Poz1 
protein is replaced by the structurally similar hTRF2H domain as well as its binding partner 
hApollo. In a first step, the poz1 gene was deleted. In a subsequent step, TRF2
40-245
 was fused 
to the C-terminus of Rap1 with a 6x glycine linker in between allowing a certain degree of 
flexibility so that it can find and form the interaction with Apollo. Finally, a minimal peptide 
of Apollo (495-530) that is known to interact with TRF2H (Chen et al., 2008), was fused to 
the C-terminus of Tpz1. Again a 6x glycine linker was introduced in between Tpz1 and 
Apollo allowing the short binding domain of Apollo to protrude from the Tpz1 C-terminus 
und reach its binding pocket in TRF2H. In theory, Rap1-TRF2H should interact with Apollo-
Tpz1 thereby reconstituting the bridge between the double- and single-strand binding 
complexes in a similar way in which Poz1 forms a bridge in wildtype cells (figure 4.22). 
Importantly, TRF2H-Apollo should merely restore the link between the subcomplexes, but 
they also represent a structurally highly similar substitute that should ensure the integrity of 
the dimeric arrangement throughout the shelterin complex. 
 
 
 
Figure 4.22. Schematic view of the shelterin complex of the generated spRap1-hTRF2H-hApollo-spTpz1 fission yeast 
strain. 
The TRF2H-domain is fused to the C-terminus of Rap1 and the Apollo peptide is fused to the C-terminus of Tpz1.  
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The telomeric length of the resulting chimeric TRF2H-Apollo strain was determined 
and compared to that in wildtype cells (figure 4.23). 
 
 
Figure 4.23. Telomere length assay for the Rap1-TRF2H-Tpz1-Apollo fusion strain. 
Telomeres were analyzed at two time points: After 0 and after 5 restreaks. The strain containing the engineered TRF2-
Apollo bridge shows slightly shorter telomeres (lane 4) than the wildtype strain after 5 restreaks (lane 1). Although the poz1 
gene was deleted, No telomere elongation was observed in the Rap1-TRF2H-Tpz1-Apollo fusion strain (4) in contrast to the 
Poz1Δ strain (lane 2). Expression was verified by western blot.  
 
 
At first, after 0 restreaks, the fusion strain showed slightly longer telomeres than 
wildtype cells which is likely due to the way the strain was generated, meaning the deletion of 
poz1 in the first step lead to telomere elongation, and only later the fusions were inserted in 
the next two steps. After 5 restreaks we observed mild telomere shortening. Remarkably, the 
experiment reveals that the engineered TRF2H-Apollo-bridge can rescue the “very long 
telomeres” phenotype of Poz1Δ strains. Given these findings, the primary role of Poz1 must 
be the linkage of Rap1 and Tpz1. Furthermore, the experiment is so efficient, because the 
Poz1-bridge is of a dimeric nature and we replaced this architecture with a structurally very 
similar assembly that maintains the tetrameric arrangement. These results further support the 
hypothesis of Poz1-Tpz1 heterotetramer in vivo.  
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Moreover, it was shown that the telomeres of the TRF2H-Apollo fusion strain 
experience slow telomere shortening (after 5 restreaks), an observation that I attribute to the 
fact that the engineered bridge is a fixed construction that cannot be opened or closed. The 
association/dissociation between Poz1 and Rap1/Tpz1, however, must be regulated. The 
inability to support this, results in telomere dysfunction. To verify that the fusion construct 
was indeed produced in the cells, we verified the expression by western blot (figure 4.24). 
Tpz1-Apollo is expressed at a lower level than Rap1-TRF2H, but according to the results of 
the telomere length assay, sufficient protein is available to form the molecular bridge. 
 
 
Figure 4.24. Western-blot for the TRF2H-Apollo fusion strain. 
In lane (1) and (2) there is Rap1 (79 kDa) and Tpz1 (58 kDa) respectively as a control. V5-tagged Tpz1-Apollo (64 kDa) and  
V5-tagged Rap1-TRF2H (105 kDa) are in lane (3).  
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5. Discussion and outlook 
 
Telomeres, the DNA-protein structures at the ends of linear chromosomal DNA have 
been shown to be of utmost importance for maintaining genomic integrity. As a consequence 
of the vast regulation mechanisms at the DNA ends, degradation and chromosome fusions are 
avoided. In recent years emerging evidence has revealed, that maintaining and protecting the 
telomeres is far more complex than the mere addition of telomeric repeats by telomerase. A 
myriad of telomere associated factors has been identified with likely more still waiting to be 
discovered. Given the fundamental importance of passing on intact genetic information upon 
cell division, our understanding of the underlying molecular mechanisms is required for the 
development of preventative measures for interrelated diseases. Importantly, the advances in 
the field of telomere biology research have uncovered the crucial role of telomere 
maintenance in development of cancer. 
 
Here we focused on the telomere-protection complex known as shelterin, which is a 
large multi-subunit protein complex present in many organisms ranging from yeast to 
humans. Its components have been shown to promote essential functions in telomere length 
control. By gaining insight into the molecular structures of some of these components, we 
have identified indispensible features that ensure the proper function of shelterin complexes 
in telomere maintenance. 
 
 While work on the human shelterin complex presented itself difficult, ultimately 
investigations on the architecturally similar fission yeast complex led to successful structure 
solution of subcomplexes. The ease of in vivo genetic manipulation in yeast allowed us 
thereafter to follow up on hypothesizes based on the complex structures. An isolated shelterin 
subcomplex composed of spPoz1-Tpz1 with boundaries obtained by limited proteolysis was 
successfully used in structure determination by X-ray crystallography.  
 
 
The Poz1-Tpz1 shelterin subcomplex 
 
Preceding this work little was known about the structure and function of the fission 
yeast shelterin component Poz1 (Miyoshi et al., 2008). Based on the protein sequence, no 
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motifs or sequence similarity to any other proteins could be identified. Through the results 
presented here, we have uncovered several new features of the Poz1-Tpz1 shelterin 
subcomplex. The structure allowed us to improve our knowledge of the overall shelterin 
architecture and revealed some striking similarities to the human shelterin proteins. 
 
 
Similarity of Poz1-Tpz1 to the human shelterin components TRF1 and TRF2 
 
Despite the absence of any sequence similarity to the human shelterin components 
TRF1 and TRF2, the crystal structure of Poz1
30-249
-Tpz1
475-508 
revealed a remarkable 
structural similarity to the TRF-homology domain (TRFH). The TRFH-domain is a 
conserved dimerization module found in both TRF1 and TRF2. Interestingly, Poz1-Tpz1 is 
not the functional homologues to TRF1 or TRF2 but, according to widely accepted models, 
are the homologues of hsTIN-TPP1 (figure 5.1).  
 
                   Fission yeast 
 
                 Human 
 
Figure 5.1. Comparison of the human and the fission yeast shelterin complexes. 
 
Nevertheless, virtually every secondary structure element found in Poz1, aligns with 
those found in the human TRF proteins, albeit with some differences in length. If Poz1-Tpz1 
is structurally similar to TRF1 and TRF2, it might also be similar in structure to the presumed 
homologues TIN2-TPP1 whose structure has not been determined. Perhaps the TRFH-
domain is a conserved structural element found throughout the shelterin complexes among 
many different species. 
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A conserved binding pocket for Poz1-Tpz1, TRF1-TIN2 and TRF2-Apollo 
 
 Alignment of our Poz1-Tpz1 structure with those of TRF1-TIN2 and TRF2-Apollo 
revealed that the binding pocket for Tpz1 in Poz1 superimposes with little deviation onto the 
binding pockets of TIN2 in TRF1 and Apollo in TRF2 (section 4.3). Back in 2008, Chen et 
al. showed that TRF1 and TRF2 bind their interaction partners, TIN2 and Apollo, 
respectively, using a shared docking motif Y/F-X-L-X-P. This motif was also present in 
another TRF1 interacting protein called hPinX1. Given these findings it was proposed that 
the TRFH domains of TRF1 and TRF2 function as telomeric protein docking sites that recruit 
different shelterin-associated factors with distinct functions using a common recognition 
motif. The striking similarity of the Poz1-Tpz1 subcomplex to the TRF1-TIN2 and TRF2-
Apollo structures, raises the question whether a similar binding mode exists in Poz1-Tpz1. In 
the search for a common binding motif, we compared residues involved in the binding pocket 
in the human complex with those in the fission yeast complex. Given that there is no 
sequence similarity between the TRF proteins and Poz1-Tpz1, it is not surprising that we did 
not observe identical residues in the binding site. By structural superposition of the human 
and fission yeast binding pockets we attempted to derive a hypothetical binding motif in 
Tpz1. This consisted of the sequence (F-X)-L-X-X-X-W-X-K. A motif search in the fission 
yeast genome for F-X-L-X-X-X-W-X-K returned two proteins: the first being midasin, a 
giant AAA family ATPase whose homologue Rea1 in S. cerevisiae drives removal of 
biogenesis factors during multiple stages of 60S ribosome assembly (Bassler et al 2010). The 
second hit was an RNA-binding protein designated spCwf5 which has been proposed to act 
as a part of a pre-spliceosome complex (Ohi et al., 2002). Further work is required to 
determine whether these proteins are indeed involved with the shelterin complex. When 
searching for the less restrictive motif L-X-X-X-W-X-K, many more hits were found. The 
protein of interest among these was the protein spTaf1 which is known to interact with Taz1 
(Ueno et al, 2001). This finding is particularly interesting because Taz1 has also been 
predicted to contain a TRFH-like domain (Li et al., 2000). We propose that Taz1 also binds 
proteins in its TRFH-domain and recognizes them via a specific motif. Given the 
conservation of the TRFH-domain it is possible that the recognition motif in proteins binding 
to spTaz1 is similar to that in proteins that bind to Poz1. Since Taf1 binds Taz1, we do not 
expect it to bind Poz1 as well. Rather we suggest that Taf1 turned up in the motif search 
because of a similar but not identical recognition motif. Possibly, we have identified a part of 
a motif that is similar among Taz1- and Poz1-binding proteins, and the remaining sequence 
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specific for Poz1 remains unknown. Further investigations will help to define the motif more 
specifically. Moreover, examination of the proteins retrieved in the motif search is required to 
determine their possible involvement at the shelterin complex. The next step would be to 
determine whether Taf1 indeed binds to the Taz1 TRFH domain. Also, using the Poz1 TRFH 
domain as bait, we could try to fish for further hypothetical binding partners in yeast lysate 
and compare the results with the proteins retrieved in the motif search. 
 
 
Poz1-Tpz1 heterotetramerization 
 
The TRFH domain functions as a dimerization module in TRF1 and TRF2 (Spink et 
al., 2000). Consequently, TRF1 and TIN2 as well as TRF2 and Apollo form heterotetramers. 
Given the high degree of structural similarity of Poz1-Tpz1 to the TRFH domain, we 
speculated that Poz1-Tpz1 might also be involved in heterotetramerization. In a first step we 
identified a hypothetical heterotetramer in the crystal lattice. Subsequent mutational analysis 
of the hypothetical heterotetramerization interface by analytical size exclusion 
chromatography and light scattering, revealed that indeed Poz1-Tpz1 forms heterotetramers 
in solution. However, we found that Poz1 by itself is monomeric and only upon binding to 
Tpz1 a heterotetrameric complex forms. 
 
To address the question whether heterotetramerization is merely an artifact in 
solution, or whether Poz1-Tpz1 exists as heterotetramers in vivo, we examined telomere 
length regulation in a heterotetramerization mutant in fission yeast cells. Cells expressing the 
Poz1-Tpz1 heterotetramerization mutant, showed dramatically elongated telomeres compared 
to wildtype cells, demonstrating that heterotetramerization is essential for proper telomere 
regulation. Strains containing the N-terminally truncated Poz1
30-249 
used for crystallization 
showed mildly longer telomeres compared to wildtype cells. It seems that here, the 
heterotetrameric complex loses some stability due to the missing N-terminal helix that, based 
on secondary structure predictions, is located at the heterotetramerization interface. This 
could explain the possible monomer-dimer equilibrium observed in the light scattering 
experiment. A less stable heterotetramer could lead to the mild telomere elongation 
phenotype that did not show complete telomere length deregulation.  
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If Poz1-Tpz1 is found as a heterotetramer in the shelterin complex, how does 
disrupting the heterotetramerization interface disturb the shelterin regulation system? It is 
well known that Taz1 binds the double-strand telomeric repeats as dimers, and that two 
spRap1 molecules bind the Taz1 dimer. In a recent study by Nandakumar and Cech (2012), it 
was reported that depending on the single-stranded telomeric substrate, Pot1 can dimerize 
upon DNA binding. It has been suggested that Pot1 may recruit two Tpz1 molecules and 
these in turn could bind two Ccq1 molecules assisting the recruitment of dimeric telomerase 
(Assuming that fission yeast telomerase is dimeric, as it has been shown for telomerase of 
many other organisms from ciliates to humans, section 1.2). We find that the 
heterotetramerization characteristics of Poz1-Tpz1 fits well with an overall dimeric shelterin 
complex: Our updated model suggests that a Taz1 dimer binds to the telomeric repeat and is 
bound by two Rap1 molecules. Then monomeric Poz1 binds to Tpz1 which induces 
heterotetramerization and Poz1 subsequently acts as a dimeric adaptor that can bind the two 
Rap1 molecules. Then two Tpz1 molecules interact with two Ccq1 molecules and two Pot1 
molecules. Depending on the single-stranded telomeric substrate, only one of the Pot1 
molecules can bind to the DNA or, given the right substrate, two Pot1 molecules, now in 
close proximity, could dimerize on the DNA upon binding. For Tpz1 the ability to self 
dimerize has not been shown. It is possible that the two Tpz1 molecules that are bound to the 
Poz1-dimer function as flexible arms. This would allow the Pot1 molecules to bind different 
telomeric repeats in the case where Pot1 does not dimerize (figure 5.2C). 
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A 
 
B 
 
C 
 
Figure 5.2. View of how the shelterin complexes could be arranged at the telomeric end.  
A) Poz1-dimers links arrays of Taz1-Rap1 complexes. B) Poz1-Tpz1-heterotetramers bind Taz1-Rap1-heterotetramers and 
each shelterin complex stays separate. C) Two Tpz1 molecules are bound but are not dimeric and have the Pot1 molecules 
sitting on flexible arms allowing them to bind different telomeric repeats. 
 
 
An alternative explanation could be that the Poz1-dimer acts as a bridge linking two 
Taz1-Rap1-heterotetramers in a similar way that TIN2 links the two human double-strand 
binding complexes, TRF1 and TRF2 (figure 5.2A). This would lead to arrays of Taz1-Rap1 
molecules: A Rap1 molecule would be connected to a Rap1 molecule of a neighboring Taz1-
Rap-heterotetramer. The formation of arrays is a possible explanation for the tendency of 
these proteins to aggregate during protein purification. Tpz1-Pot1 molecules could then be 
docked on top of the array and could bind the folded back 3’ telomeric overhang to form the 
T-loop structure. Should it not be the case that Poz1-dimers link arrays of Taz1-Rap1 
complexes a Poz1-dimer might bind one Rap1-dimer and this would still allow binding of the 
folded back telomeric overhang (figure 5.2B). 
 
Currently all of the scenarios described above are possible and further experiments 
should be performed in order to clarify which represents reality. Analysis of different 
combinations of shelterin components by electron microscopy could shed light on some 
higher order arrangements. 
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An essential zinc-binding site at the interface of Poz1 and Tpz1 
 
Furthermore, our structure revealed a unique feature of Poz1-Tpz1 that is not present 
in the structurally similar TRF1 and TRF2, which is the binding site for a zinc ion. The metal 
ion is coordinated by three residues provided by Tpz1 and one residue by Poz1. An initial 
hypothesis, that the binding of zinc might be essential for Poz1-Tpz1 complex formation, was 
disproved by an affinity pulldown experiment with a mutant containing a disrupted zinc site. 
In vitro, the mutant showed no difference in expression level and interaction compared to the 
wildtype proteins implying that the complex was still readily formed. Surprisingly, the metal 
site was not essential for complex formation. Then what is its function? To follow up on this 
question we further determined the telomeric length of cells containing the zinc site 
disruption mutations in their genome. These cells exhibited dramatically elongated telomeres 
compared to wildtype cells, similar to what was observed in Poz1Δ strains. What does the 
inhibition of zinc binding disturb in the telomere length regulation system? A possible 
explanation for the observed effects is that failure to bind zinc might cause destabilization of 
the Poz1-Tpz1 heterotetramer. This assumption is supported by the fact that the zinc binding 
site lies in close proximity to the helix α1 of Poz1 that forms major contacts in the 
heterotetrameric assembly. The inability to bind zinc might cause a conformational change of 
the secondary structure elements involved at the heterotetramerization interface, no longer 
allowing multimerization. Using size-exclusion chromatography we attempted to test whether 
the zinc site mutant remains to support the formation of heterotetramers. Due to precipitation 
of the protein after affinity chromatography the experiment was unsuccessful. Possibly, the 
inability to retain the zinc ion disrupts the integrity of the complex (or at least parts of it since 
Poz1 stills binds Tpz1) and decreases protein solubility. We propose that failure to bind zinc 
also results in protein destabilization in vivo including disruption of the heterotetramer, 
leading to the long telomere phenotype. It should be noted that the protein destabilization was 
observed in vitro for the construct boundaries Poz1
30-249
+Tpz1
475-508
 and whether structural 
destabilization also occurs in the fulllength proteins with a disrupted zinc site remains 
currently unknown. 
  
An alternative, more speculative explanation, is that instead of structural 
destabilization or disruption of the heterotetramerization interface, failure to bind the zinc 
ion, might result in a longer range conformational change in Tpz1. So far we have solved the 
structure a Tpz1 C-terminal fragment. The architecture of the remaining larger part of the 
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protein remains unknown. One possibility is that the zinc ion must be bound at all times to 
ensure the integrity of the protein structure. Another possibility is that association and 
dissociation of the zinc ion and conformational changes resulting thereof are part a shelterin 
regulation mechanism. Zinc transfer could be mediated by interaction with proteins such as 
metallotheioneins and theioneins that have been implicated in metal transfer from and to zinc 
binding proteins (Margoshes and Vallee 1995, Jacob et al., 1998). 
 
 
Poz1 as a bridge linking the double- and single-strand binding complexes 
 
Poz1 bridges the double-strand and single-strand binding parts of the shelterin 
complex by linking Rap1 and Tpz1. Is this the only function of Poz1 and is the bridge a static 
construction, or can the bridge be opened and closed as part of a regulation mechanism? To 
address this question, we attempted to replace the Poz1-bridge by a structurally similar 
protein, namely human TRF2. By fusing the TRF2H dimerization domain to the C-terminus 
of Rap1, as well as a peptide of the TRF2H interacting protein Apollo to the C-terminus of 
Tpz1, we reconstructed the link that Poz1 forms in wildtype fission yeast (figure 5.3).  
 
 
 
A 
 
B 
 
Figure 5.3. Replacing the “Poz1-bridge” by an engineered TRF2H-Apollo bridge. 
A) In wildtype fission yeast, Poz1 forms a bridge between the double-strand binding shelterin complex Taz1-Rap1 and the 
single-strand binding complex Pot1-Tpz1. B) We removed Poz1 and replaced it by an engineered bridge composed of the 
human shelterin proteins TRF2H and hsApollo. Small dots indicate a covalent fusion. 
 
Indeed fission yeast cells that harbored the engineered bridge did not show the “very 
long telomere” phenotype that we would observe in Poz1Δ cells. Instead, these cells showed 
slow telomere shortening after several restreaks. Possibly, the introduction of the structurally 
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similar TRF2H domain was able to compensate for most of the function of Poz1. But why 
can a foreign species protein, which is not a functional homologue, substitute for most of the 
function of Poz1? Poz1 links the double-strand and the single-strand halves of the shelterin 
complex. This is the role that the TRF2H dimerization module fused to Rap1 and the TRF2H 
binding peptide of Apollo fused to Tpz1 take over. Besides restoration of the link between 
Rap1 and Tpz1, the high degree of structural similarity of TRF2H-Apollo and Poz1-Tpz1, 
ensures littlest possible structural distortion in the shelterin complex, as the overall 
dimensions and even the Cα-backbone are very similar. Importantly, we propose that 
TRF2H-Apollo imitates the function of Poz1 so well, since it establishes the dimeric link 
between the Rap1-dimer and the two Tpz1 molecules. Thus, I propose the primary function 
of Poz1 to be the bridging of the double-strand and the single-strand halves of the shelterin 
complex in a dimeric manner. 
 
However, the restoration of Poz1 function was not completely successful, as slow 
telomere shortening was observed in the TRF2H-Apollo strain. A likely explanation is that in 
wildtype cells, the interaction of Poz1 with Rap1 and Tpz1 is of a dynamic nature and the 
proteins associate and dissociate in a regulated manner. In the engineered fusion strain, the 
bridge is constitutive and the complex is therefore forced to remain in the closed 
conformation, which is a likely cause for the defects in telomere length homeostasis. This 
explanation is in line with the model of fission yeast telomere length regulation where in the 
“closed state” (meaning the Poz1-bridge is closed) there is no recruitment/stimulation of 
telomerase (see introduction 1.4). Since the engineered TRF2H-Apollo-bridge represents the 
closed form, telomerase might not be recruited/stimulated as suggested in the model. This 
would lead to progressive telomere shortening. On the other hand, when the Poz1-bridge is 
opened, telomerase can be recruited/stimulated. The Poz1Δ strain showed strong telomere 
elongation, indicating that Poz1 is not required for telomere elongation. However, when 
telomeres are long, Poz1 is essential for closing the bridge and thereby inhibiting elongation 
by telomerase. 
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A 
 
B 
 
C 
 
Figure 5.4. Bridging the double-strand and the single-strand shelterin complex.  
A) and B) Opening of the shelterin complex by dissociation of Poz1 from either Rap1 or Tpz1. C) The shelterin complex is 
forced into the closed state as TRF2H is fused to Rap1 and Apollo is fused to Tpz1. Since TRF2H and Apollo are human 
proteins their interaction is not regulated, not allowing the opening of the bridge. 
 
 
In the TRF2H-Apollo fusion strain we replaced Poz1 by an artificial bridge. Perhaps it 
is the missing Poz1 that is causing length deregulation and not the fact that the complex is 
kept in a closed conformation. As a future experiment we need to analyze Poz1 in the context 
of a forced “closed-state”: If we fuse Poz1 to Rap1 and Tpz1 and we see similar effects than 
what was observed in the TRF2H-Apollo fusion strain this would indicate that the mere 
presence of Poz1 as a bridge is not sufficient to maintain proper shelterin function. 
Consequently, this would show that the association and dissociation of the bridge in a 
regulated manner is of crucial importance.  
 
A future quest will be to determine additional domains of shelterin components 
besides Poz1 that are essential for shelterin function. One possible approach is to assemble a 
minimal shelterin complex: All structural elements that are required for assembly would be 
present and other regions would be systematically excluded. In such a manner we could 
identify currently unknown domains that are part or targets of regulation mechanisms. 
 
 
Final remarks 
 
By solving the structure of the Poz1-Tpz1 shelterin subcomplex and in vivo 
experiments based there on in fission yeast, we have gained insight into telomere length 
regulation and have highlighted how delicate the system is and how small changes can lead to 
severe regulation defects. Although the human shelterin complex differs from the fission 
yeast complex, many similarities can be observed and a better understanding of the system in 
yeast can be translated to the human system. Given the fact that telomere dysfunction, 
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especially length regulation, has been implicated in many human diseases including cancer, 
gaining as much knowledge as possible on the molecular workings of these mechanisms is 
paramount.   
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